Bronchitis, not specified as acute or chronic

J10_BRONCH

bronchitis: An acute or chronic inflammatory process affecting the bronchi. [database_cross_reference: NCIT:C2911]

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J40 Hospital discharge: ICD-9 — 490 Hospital discharge: ICD-8 — 49099 Cause of death: ICD-10 — J40 Cause of death: ICD-9 — 490 Cause of death: ICD-8 — 49099 2 out of 7 registries used, show all original rules.	3915
4. Check minimum number of events None	3915
5. Include endpoints None	3915
6. Filter based on genotype QC (FinnGen only)	3798

Control definitions (FinnGen only)

Control exclude: J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Bronchitis non specificata utrum acuta an chronica

NAME	J10_BRONCH
CONTROL_EXCLUDE	J10_LOWCHRON
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J40
HD_ICD_9	490
HD_ICD_8	49099
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J40
COD_ICD_9	490
COD_ICD_8	49099
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bronchitis, not specified as acute or chronic based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	45745	19996	25104
Only index persons	31269	13713	17556
Unadjusted period prevalence (%)
Whole population	0.64	0.57	0.70
Only index persons	0.60	0.50	0.67
Median age at first event (years)
Whole population	42.04	52.72	33.02
Only index persons	30.35	43.02	20.46

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3798	1718	2080
Unadjusted period prevalence (%)	0.80	0.61	0.95
Median age at first event (years)	34.09	39.64	29.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3914: Matched controls
39135

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

49300

ICD-8 Finland

Asthma, bronchiale

+∞

316.0

299

49099

ICD-8 Finland

Bronchitis, unspecified

+∞

307.7

1915

R03AK07

ATC

formoterol and budesonide; inhalant

4.5

307.7

1017

2829

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

307.7

1320

R03BA01

ATC

beclometasone; inhalant

7.3

307.7

759

1249

R03BA05

ATC

fluticasone; inhalant

5.9

307.7

974

2087

R03AK06

ATC

salmeterol and fluticasone; inhalant

10.2

307.7

859

1046

J46

ICD-10 Finland

Status asthmaticus

120.0

307.7

194

R03AC03

ATC

terbutaline; inhalant

5.6

307.7

714

1495

R03AC13

ATC

formoterol; inhalant

19.8

307.7

288

156

R03AC12

ATC

salmeterol; inhalant

56.7

307.7

361

J45.9

ICD-10 Finland

Asthma, unspecified

30.6

307.7

1129

512

R03BB04

ATC

tiotropium bromide; inhalant

20.6

307.7

644

371

R03DA04

ATC

theophylline; systemic, rectal

15.8

307.7

397

278

J45.8

ICD-10 Finland

Mixed asthma

201.8

307.7

192

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

176.6

307.7

169

R96

ICPC

Asthma

14.3

307.7

452

353

J45.1

ICD-10 Finland

Nonallergic asthma

113.4

307.7

416

R03BA02

ATC

budesonide; inhalant

7.3

307.7

1016

1786

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

+∞

307.7

678

R03AC02

ATC

salbutamol; inhalant

4.7

307.7

2583

11509

J45

ICD-10 Finland

Asthma

14.0

307.7

499

403

J45.0

ICD-10 Finland

Predominantly allergic asthma

78.0

307.7

539

R03DC03

ATC

montelukast; oral

6.8

307.7

869

1570

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

36.5

307.7

521

164

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

49.0

307.7

231

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

78.3

307.7

1389

273

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

85.5

307.7

271

H02AB06

ATC

prednisolone; systemic

3.3

298.7

2147

10428

R03BB01

ATC

ipratropium bromide; inhalant

13.1

294.6

289

237

R03AK08

ATC

formoterol and beclometasone; inhalant

21.1

293.2

223

112

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.8

271.9

1057

3466

R03AK03

ATC

[U] fenoterol and ipratropium bromide

9.3

271.3

341

399

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

73.1

261.1

141

H02AB04

ATC

methylprednisolone; systemic

3.8

201.4

734

2266

R03BA08

ATC

ciclesonide; inhalant

5.8

192.4

372

693

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.9

176.9

423

949

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.7

174.4

287

455

J47

ICD-10 Finland

Bronchiectasis

875.9

172.3

168

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

171.5

1235

5625

J01FA06

ATC

roxithromycin; oral

2.5

167.1

1744

9480

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

10.4

163.9

185

186

H02AB07

ATC

prednisone; oral

3.4

152.9

651

2198

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

147.8

141

XG474

NOMESCO Finland

Exhalation nntrogen oxide

13.3

146.4

140

109

J01AA02

ATC

doxycycline; systemic

2.8

142.7

3136

23198

XG410

NOMESCO Finland

Flow-volume spirometry

6.8

131.8

211

324

R06.0

ICD-10 Finland

Dyspnoea

2.5

131.6

1090

5215

J01MA14

ATC

moxifloxacin; systemic

3.6

129.4

461

1381

48609

ICD-8 Finland

Pneumonia, unspecified

8.6

128.8

168

204

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

127.8

122

R95

ICPC

Chron obstructive pulmonary disease

17.3

124.8

103

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

6.2

121.0

213

360

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

7.0

117.7

184

275

R03DC01

ATC

zafirlukast; oral

17.9

114.8

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

7.8

114.0

160

212

R02

ICPC

Shortness of breath/dyspnoea

3.1

109.0

516

1836

R03AK11

ATC

formoterol and fluticasone; inhalant

12.7

106.2

104

J42

ICD-10 Finland

Unspecified chronic bronchitis

19.6

99.1

R06.2

ICD-10 Finland

Wheezing

5.4

97.3

199

387

R05

ICD-10 Finland

Cough

2.3

93.8

850

4156

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

92.8

437

1544

R03BC01

ATC

cromoglicic acid; inhalant

12.6

92.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

90.7

1987

13480

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.8

90.1

144

220

1240

FHL

Bronchoscopy

9.3

89.2

108

119

R03BC03

ATC

nedocromil; inhalant

3.6

87.3

302

881

J01MA12

ATC

levofloxacin; systemic

2.3

86.9

793

3876

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.4

86.6

328

1015

48509

ICD-8 Finland

Bronchopneumonia, unspecified

7.9

84.3

116

150

J43.9

ICD-10 Finland

Emphysema, unspecified

37.6

83.9

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

27.5

83.8

J96.1

ICD-10 Finland

Chronic respiratory failure

9.3

83.6

101

111

J01FA10

ATC

azithromycin; systemic

1.9

82.9

2105

14831

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

80.8

1725

11458

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

20.6

80.3

R04.2

ICD-10 Finland

Haemoptysis

4.8

79.4

184

398

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

11.8

78.3

R06AE07

ATC

cetirizine; oral

1.9

77.2

1583

10336

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

5.1

76.5

164

332

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

76.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.9

76.2

402

1507

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

75.2

1784

12170

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.2

74.9

208

519

J01FA09

ATC

clarithromycin; systemic

2.0

72.7

1154

6895

R05

ICPC

Cough

2.1

71.5

862

4667

J20

ICD-10 Finland

Acute bronchitis

2.7

71.3

407

1588

Y0499

ICD-8 Finland

Investigation of respiratory system

8.9

71.3

102

R01AD08

ATC

fluticasone; nasal

2.0

70.3

1044

6087

N02AX02

ATC

tramadol; systemic, rectal

1.8

69.9

1656

11214

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

69.4

870

4774

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.4

69.0

255

775

R03BB02

ATC

oxitropium bromide; inhalant

21.1

66.4

R01AD09

ATC

mometasone; nasal

1.8

64.9

1595

10853

C03CA01

ATC

furosemide; systemic

1.9

64.8

1184

7360

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.0

64.1

953

5532

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

12.0

63.5

XG405

NOMESCO Finland

Education on PEF monitoring

10.5

62.4

XQ800

NOMESCO Finland

Prick test

3.2

61.1

252

819

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

11.2

58.9

R01BA52

ATC

pseudoephedrine, combinations; oral

1.9

58.2

1059

6536

SPAT1059

SPAT

Spirometry at the office

3.9

58.0

178

477

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

57.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.8

57.4

181

494

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

5.2

56.8

119

236

R05FB02

ATC

cough suppressants and expectorants; systemic

1.8

56.5

1376

9245

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

121.8

55.9

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

23.8

55.7

J01DA01

ATC

[U] cefalexin

1.7

55.6

2314

17952

N03AX16

ATC

[U] pregabalin

1.9

55.1

868

5104

J01CA04

ATC

amoxicillin; systemic

1.8

54.8

2986

24932

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

54.3

981

6020

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

54.3

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

2.3

53.2

422

1915

J41.0

ICD-10 Finland

Simple chronic bronchitis

17.7

51.5

R05CB01

ATC

acetylcysteine; inhalant, oral

6.6

51.4

128

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

50.0

1418

9854

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

20.7

48.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

48.6

1035

6635

A02BC03

ATC

lansoprazole; oral

1.8

48.2

1040

6691

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.6

48.1

117

263

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

48.0

SPAT1058

SPAT

PEF monitoring instruction

2.8

48.0

246

903

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

46.8

142

377

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

46.6

681

3884

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

46.4

1283

8815

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

45.9

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.7

45.0

106

232

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

2.5

44.6

292

1212

J01FA15

ATC

telithromycin; oral

2.3

43.8

357

1634

J01DA06

ATC

[U] cefuroxime

2.0

43.7

524

2789

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

43.5

1019

6675

A02BA02

ATC

ranitidine; systemic

1.8

43.5

730

4342

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

43.2

525

2806

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

42.8

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

42.8

A02BC02

ATC

pantoprazole; systemic

1.6

42.5

2411

19582

R29

ICPC

Respiratory symptom/complaint other

2.7

42.4

245

956

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.0

42.3

195

675

R51.80

ICD-10 Finland

Headache

2.0

42.0

550

3017

R81

ICPC

Pneumonia

3.5

41.4

148

439

R01AD05

ATC

budesonide; nasal

2.5

41.3

268

1107

J01FA01

ATC

erythromycin; systemic

2.0

41.1

498

2657

A02BC05

ATC

esomeprazole; systemic

1.6

40.1

1415

10242

N06AB04

ATC

citalopram; systemic

1.8

39.8

758

4672

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.4

39.7

146

441

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

6.3

38.9

104

A02BC01

ATC

omeprazole; systemic

1.7

38.9

971

6442

SPAT1257

SPAT

Teaching of medicine inhalation technique

4.2

38.5

104

254

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

6.4

38.0

100

R03CC02

ATC

salbutamol; systemic

3.2

37.7

154

497

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

10.1

37.1

G47.3

ICD-10 Finland

Sleep apnoea

1.7

36.7

795

5066

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

5.1

36.7

153

R01AD12

ATC

fluticasone furoate; nasal

1.6

36.7

1008

6837

J01DB01

ATC

cefalexin; oral

1.6

36.6

3003

26101

49309

ICD-8 Finland

Asthma, Unspecified

+∞

36.5

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

7.4

36.0

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

35.9

532

3029

M03BX02

ATC

tizanidine; oral

1.5

35.7

2168

17551

R01AD58

ATC

fluticasone, combinations; nasal

1.7

35.7

772

4915

J01FF01

ATC

clindamycin; systemic

1.6

35.5

943

6333

50709

ICD-8 Finland

Hay fever, Unspecified

8.2

35.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

34.9

889

5903

78310

ICD-8 Finland

Symptoms referable to respiratory system, Haemoptysis

14.0

34.8

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

6.0

34.6

103

R06AX22

ATC

ebastine; oral

1.8

34.5

553

3224

51899

ICD-8 Finland

Bronchiectasis

+∞

34.4

C07AB07

ATC

bisoprolol; oral

1.5

34.3

1685

13001

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.6

34.1

115

R06AX27

ATC

desloratadine; oral

1.6

33.9

876

5832

A07AA02

ATC

nystatin; oral

2.6

33.7

210

850

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

33.5

459

2544

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

33.4

662

4106

A01AB09

ATC

miconazole; local oral

2.2

33.3

290

1361

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

33.3

347

1748

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

33.3

256

1141

M54.5

ICD-10 Finland

Low back pain

1.6

33.3

1215

8777

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

33.2

762

4916

SPAT1254

SPAT

Administration of medicine

1.8

33.0

512

2952

R50.9

ICD-10 Finland

Fever, unspecified

1.8

32.6

537

3154

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

32.4

279

1304

49308

ICD-8 Finland

Asthma, Alia definita

+∞

32.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

32.1

223

950

L28

ICPC

Limited function/disability (L)

1.8

32.1

605

3697

J01MA02

ATC

ciprofloxacin; systemic

1.5

31.6

1378

10317

R03DA05

ATC

aminophylline; systemic, rectal

8.9

31.6

J01DA09

ATC

[U] cefadroxil

1.6

31.5

919

6288

R06AX13

ATC

loratadine; oral

1.9

31.1

466

2657

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

31.0

719

4643

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.1

30.8

130

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

30.6

340

1752

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

30.6

192

780

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

30.3

411

2267

J02AC01

ATC

fluconazole; systemic

1.5

30.1

1191

8713

R42

ICD-10 Finland

Dizziness and giddiness

1.6

30.0

781

5189

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.7

30.0

100

A03FA02

ATC

cisapride; oral, rectal

2.1

29.9

281

1359

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

29.9

340

1767

R01AD11

ATC

triamcinolone; nasal

2.1

29.8

292

1435

P01AB01

ATC

metronidazole; oral, rectal

1.5

29.8

1298

9690

SPAT1263

SPAT

Sampling

1.5

29.6

1393

10558

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

29.2

425

2398

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

29.2

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

28.9

195

820

E0000UV, ,

ATC

1.5

28.3

1354

10277

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

+∞

28.2

R78

ICPC

Acute bronchitis/bronchiolitis

4.1

27.5

189

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

27.4

590

3726

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

27.4

1512

11780

UJF32

NOMESCO Finland

Coloscopy

1.6

27.4

853

5900

R53

ICD-10 Finland

Malaise and fatigue

1.6

27.3

824

5660

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

6.8

27.1

M79.6

ICD-10 Finland

Pain in limb

1.5

27.1

1356

10361

N03AX12

ATC

[U] gabapentin; oral

1.7

27.0

537

3318

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

27.0

968

6904

R74

ICPC

Upper respiratory infection acute

1.5

26.8

962

6862

N05BA01

ATC

diazepam; systemic, rectal

1.8

26.7

458

2713

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

26.5

186

796

J37.0

ICD-10 Finland

Chronic laryngitis

3.0

26.3

116

392

N06AA09

ATC

amitriptyline; systemic

1.9

26.2

328

1759

XG466

NOMESCO Finland

Sleep oxymetry

3.2

26.1

107

346

R01AD01

ATC

beclometasone; nasal

1.8

26.1

475

2862

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

26.1

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

26.1

267

1334

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

25.9

446

2646

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

25.8

1090

8035

TGC00

NOMESCO Finland

Bronchial lavation

3.5

25.6

260

R03CC03

ATC

terbutaline; systemic

4.0

25.4

187

N05BA04

ATC

oxazepam; oral

1.5

25.2

874

6175

N06AX21

ATC

duloxetine; oral

1.8

25.2

382

2180

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

24.9

847

5958

A03

ICPC

Fever

1.7

24.9

531

3340

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

9.7

24.1

A02BA04

ATC

nizatidine; systemic

2.0

24.1

274

1422

R03AC04

ATC

fenoterol; inhalant

56.4

24.0

R60.0

ICD-10 Finland

Localized oedema

1.8

24.0

398

2333

J33.0

ICD-10 Finland

Polyp of nasal cavity

3.2

23.8

308

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

23.8

160

672

A01AB10

ATC

natamycin; local oral

3.0

23.7

103

345

N05CF01

ATC

zopiclone; oral

1.5

23.7

1107

8298

C01DA14

ATC

isosorbide mononitrate; oral

1.6

23.6

570

3697

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

23.6

546

3504

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

23.6

283

1496

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

23.4

700

4777

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

23.2

1387

10873

A01AB04

ATC

amphotericin B; local oral

2.4

23.1

157

662

N05CD07

ATC

temazepam; oral

1.7

23.1

426

2574

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

22.8

637

4279

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

22.6

555

3612

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

22.6

355

2046

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

19.0

22.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

22.5

126

484

N02AC04

ATC

dextropropoxyphene; oral

2.4

22.5

150

627

46401

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)

4.8

22.4

105

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

32.4

22.4

R13

ICD-10 Finland

Dysphagia

2.0

22.2

232

1167

4451

FHL

Guitar cutting

2.9

22.2

106

375

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

21.9

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

21.9

R07.3

ICD-10 Finland

Other chest pain

1.8

21.8

345

1992

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.4

21.8

151

643

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

21.7

574

3801

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

21.7

813

5815

J01MA01

ATC

ofloxacin; systemic

1.9

21.6

298

1648

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

21.5

327

1866

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

21.4

365

2154

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

21.4

264

1408

L03

ICPC

Low back symptom/complaint

1.5

21.2

852

6178

I50.0

ICD-10 Finland

Congestive heart failure

1.9

21.1

258

1372

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

20.9

424

2625

S06.0

ICD-10 Finland

Concussion

1.7

20.9

369

2199

N06AA12

ATC

doxepin; systemic

2.2

20.9

181

847

R05CB03

ATC

carbocisteine; oral

3.1

20.7

276

M48.0

ICD-10 Finland

Spinal stenosis

1.7

20.7

388

2353

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

20.6

821

5940

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

20.6

720

5073

D07AC01

ATC

betamethasone; topical

1.4

20.5

1161

8971

N05AH04

ATC

quetiapine; oral

1.6

20.5

574

3850

R52.9

ICD-10 Finland

Pain, unspecified

1.8

20.4

308

1753

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

20.4

500

3250

R05CB02

ATC

bromhexine; systemic

3.9

20.3

157

N06AX11

ATC

mirtazapine; oral

1.4

20.3

1095

8388

C01CA24

ATC

epinephrine; parenteral

2.2

20.1

170

788

A06AD11

ATC

lactulose; oral

1.6

20.1

520

3422

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

19.9

392

2408

N06AX16

ATC

venlafaxine; oral

1.7

19.8

427

2686

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

19.7

540

3601

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

19.7

279

1556

4640A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngitis

6.3

19.7

N02AA05

ATC

oxycodone; systemic

1.6

19.6

568

3836

J01DC02

ATC

cefuroxime; systemic

2.1

19.5

179

857

E000001, ,

ATC

1.5

19.5

617

4249

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.7

19.4

105

397

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

19.3

115

456

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

31.4

19.2

SPAT1216

SPAT

Assessment of functional ability

1.6

19.2

495

3252

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

19.2

1005

7639

R06AE09

ATC

levocetirizine; oral

1.7

19.2

402

2509

M01AE02

ATC

naproxen; oral, rectal

1.4

19.2

1866

15709

R04

ICPC

Breathing problem other

2.5

19.1

117

470

G44.2

ICD-10 Finland

Tension-type headache

1.7

19.1

406

2545

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

19.0

409

2570

N02BE01

ATC

paracetamol; systemic, rectal

1.5

19.0

3148

28869

R05DB20

ATC

other cough suppressants - combinations

2.1

19.0

183

894

M01AH02

ATC

rofecoxib; oral

1.7

19.0

409

2572

R52.2

ICD-10 Finland

Other chronic pain

2.4

18.9

128

539

R49.01

ICD-10 Finland

Functional dysphonia

2.8

18.9

346

K30

ICD-10 Finland

Functional dyspepsia

1.7

18.8

341

2046

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

18.8

360

2194

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

18.8

247

1346

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

18.7

344

2074

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

18.6

307

1794

M25.5

ICD-10 Finland

Pain in joint

1.4

18.5

981

7468

SPAT1262

SPAT

Handing over of treatment supplies

1.5

18.3

558

3809

J30.3

ICD-10 Finland

Other allergic rhinitis

2.6

18.3

102

392

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

18.2

511

3423

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

18.2

874

6532

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

18.2

127

543

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

18.2

908

6837

SPAT1229

SPAT

Assessment of need for aid

1.8

18.1

256

1427

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

18.1

1220

9666

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

18.1

293

1702

J32.4

ICD-10 Finland

Chronic pansinusitis

4.3

18.0

108

J33.8

ICD-10 Finland

Other polyp of sinus

3.5

18.0

171

A10BA02

ATC

metformin; oral

1.4

18.0

926

7007

M04AA01

ATC

allopurinol; systemic

1.6

17.9

442

2872

A46

ICD-10 Finland

Erysipelas

1.6

17.9

471

3109

R03BB07

ATC

umeclidinium bromide; inhalant

16.6

17.8

R03AC18

ATC

indacaterol; inhalant

26.8

17.8

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

26.8

17.8

R05DB05

ATC

pentoxyverine; oral, rectal

2.4

17.8

123

524

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

17.7

459

3017

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

+∞

17.7

49102

ICD-8 Finland

Chronic bronchitis, Purulenta

+∞

17.7

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

17.7

204

1064

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

17.6

383

2414

R28

ICPC

Limited function/disability (R)

4.4

17.5

T90

ICPC

Diabetes non-insulin dependent

1.5

17.4

737

5376

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.0

17.3

262

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

17.2

360

2245

C03DA01

ATC

spironolactone; oral

1.7

17.2

373

2348

N06AB06

ATC

sertraline; oral

1.7

17.1

344

2124

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

17.1

175

875

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

17.0

396

2536

78329

ICD-8 Finland

Symptoms referable to respiratory system, Dyspnoea alia sive NUD

7.5

17.0

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

16.9

230

1267

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.7

16.9

344

N06AB03

ATC

fluoxetine; oral

1.6

16.9

366

2303

SPAT1057

SPAT

Peak expiratory flow measurement

3.9

16.9

127

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

16.9

669

4816

AA1AD

NOMESCO Finland

CT of head and brain

1.4

16.9

863

6513

R09

ICPC

Sinus symptom/complaint

1.9

16.8

234

1298

D02AE01

ATC

carbamide; topical

1.9

16.8

199

1047

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

16.8

745

5478

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

16.8

332

2039

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

16.8

192

998

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

+∞

16.7

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

16.7

131

590

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

16.6

199

1052

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

16.5

702

5120

J01DA08

ATC

[U] cefaclor

1.7

16.4

292

1742

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

16.4

302

1819

N02BF02

ATC

pregabalin; oral

2.0

16.3

179

918

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

5.5

16.2

A02BX02

ATC

sucralfate; oral

2.2

16.1

139

650

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.9

16.1

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

16.1

409

2674

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

16.1

760

5648

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

30.1

16.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

16.1

224

1243

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.9

16.1

268

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.0

1276

10335

R03BB06

ATC

glycopyrronium bromide; inhalant

33.5

15.7

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

15.6

834

6328

4911A

ICD-9 Finland

Chronic bronchitis, Mucopurulent chronic bronchitis

+∞

15.6

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

15.6

907

6982

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

15.6

341

AN1

Coronary angiography

1.6

15.5

344

2177

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

15.5

498

3433

L01

ICPC

Neck symptom/complaint

1.5

15.4

448

3020

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

15.4

226

1275

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.8

15.4

122

79388

ICD-8 Finland

Observation, without need for further medical care, Morbi alii definiti

5.2

15.3

N07BA03

ATC

varenicline; oral

2.1

15.3

143

691

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.7

15.3

127

N02BF01

ATC

gabapentin; oral

1.8

15.2

242

1399

S80.0

ICD-10 Finland

Contusion of knee

1.8

15.1

218

1224

M01AH01

ATC

celecoxib; oral

1.5

15.0

549

3881

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

15.0

1190

9607

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

15.0

187

R06.4

ICD-10 Finland

Hyperventilation

3.5

15.0

143

B01AA03

ATC

warfarin; systemic

1.4

15.0

648

4734

SPAT1260

SPAT

Consultation of another employee

1.5

14.9

513

3582

E000002, ,

ATC

1.7

14.9

317

1983

N05BA12

ATC

alprazolam; oral

1.7

14.9

314

1960

SPAT1310

SPAT

Counselling related to known health issue

1.4

14.9

937

7301

4224

FHL

Endonasal anthrostomy

4.2

14.8

L02

ICPC

Back symptom/complaint

1.7

14.8

287

1753

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

14.8

121

555

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

14.8

158

803

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.5

14.7

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

25.1

14.7

S18

ICPC

Laceration/cut

1.3

14.7

1408

11679

R06AX12

ATC

terfenadine; oral

2.1

14.6

142

696

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.2

14.6

122

564

R05DA01

ATC

ethylmorphine; oral

1.8

14.6

239

1393

S97

ICPC

Chronic ulcer skin

1.9

14.6

187

1011

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

14.6

405

2702

L17

ICPC

Foot/toe symptom/complaint

1.4

14.3

833

6403

J01EA01

ATC

trimethoprim; systemic

1.4

14.3

785

5976

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

14.3

178

954

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

14.2

183

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.3

14.2

C01AA05

ATC

digoxin; systemic

1.7

14.2

290

1797

R11

ICD-10 Finland

Nausea and vomiting

1.7

14.2

267

1619

M01AB05

ATC

diclofenac; systemic, rectal

1.3

14.1

2243

19877

A01

ICPC

Pain general/multiple sites

1.7

14.1

269

1637

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

14.0

161

839

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

14.0

120

561

SPAT1325

SPAT

Vaccination

1.4

14.0

970

7663

M02AA07

ATC

piroxicam; topical

1.3

13.9

1143

9254

XG460

NOMESCO Finland

Short time oxymetry

3.4

13.9

150

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

13.9

775

5913

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

13.8

595

4336

M79.1

ICD-10 Finland

Myalgia

1.5

13.8

421

2867

R79

ICPC

Chronic bronchitis

23.8

13.8

4226

FHL

Posterior radical surgery and possible etmoidectomy

4.6

13.7

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.5

13.7

132

N03AG01

ATC

valproic acid; systemic, rectal

1.8

13.7

190

1053

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

13.6

209

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

13.6

878

6854

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

13.5

215

1242

N05BB01

ATC

hydroxyzine; systemic

1.8

13.5

188

1043

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

13.5

122

582

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.7

13.5

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.3

13.5

100

440

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

13.5

474

3324

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

13.4

107

486

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

18.3

13.3

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.0

13.3

191

S01GX02

ATC

levocabastine; ophthalmic

1.9

13.2

158

835

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.2

1254

10349

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

13.2

461

3227

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

13.2

1289

10680

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

13.2

1467

12368

SPAT1255

SPAT

Intravenous administration of medicine

1.8

13.1

209

1208

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

13.1

762

5845

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

13.1

2320

20746

D07AA02

ATC

hydrocortisone; topical

1.5

13.1

396

2691

T82

ICPC

Obesity

2.2

13.1

112

524

K59.0

ICD-10 Finland

Constipation

1.9

13.0

173

947

R01AC01

ATC

cromoglicic acid; nasal

2.2

13.0

104

473

40199

ICD-8 Finland

Essential benign hypertension

2.5

13.0

312

SPAT1301

SPAT

No procedures

1.3

13.0

934

7405

E66.8

ICD-10 Finland

Other obesity

2.0

13.0

148

770

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

13.0

215

1258

SPAT1312

SPAT

General health counselling

1.3

12.9

926

7342

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

12.8

267

1663

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

12.8

357

N06AX03

ATC

mianserin; oral

2.0

12.7

143

740

4222

FHL

Endonasal etmoidectomy

5.8

12.7

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

12.7

131

658

R51.81

ICD-10 Finland

Facial pain NOS

2.6

12.7

292

UJD02

NOMESCO Finland

Gastroscopy

2.0

12.7

146

762

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

12.7

1745

15092

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

12.7

328

2152

A28

ICPC

Limited function/disability NOS

1.4

12.7

515

3711

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

12.7

409

2817

A04

ICPC

Weakness/tiredness general

1.5

12.6

434

3029

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

12.6

710

5419

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

12.5

294

1885

348

Kela drug reimbursment

Roflumilast

+∞

12.5

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

12.5

116

560

C08DA01

ATC

verapamil; systemic

2.0

12.5

128

642

48099

ICD-8 Finland

Viral pneumonia

9.3

12.4

51900

ICD-8 Finland

Other diseases of respiratory system, Atelectasis pulmonis

24.4

12.4

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

12.4

144

754

SPAT1211

SPAT

Application of soft bandage

1.7

12.4

250

1544

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

12.4

381

B37.0

ICD-10 Finland

Candidal stomatitis

4.0

12.4

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

12.2

183

1039

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

12.2

674

5123

L20.0

ICD-10 Finland

Besnier prurigo

1.8

12.2

180

1019

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

12.1

384

Z00.8

ICD-10 Finland

Other general examinations

1.7

12.1

234

1430

H65.3

ICD-10 Finland

Chronic mucoid otitis media

3.0

12.0

175

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

12.0

234

1433

A02BA03

ATC

famotidine; systemic

2.0

11.9

120

597

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

11.9

345

2320

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

11.9

223

1351

SPAT1240

SPAT

Therapeutic discussion

1.6

11.9

290

1877

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

11.8

295

1918

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

11.8

186

1073

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

11.8

148

796

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.6

11.8

250

R09.1

ICD-10 Finland

Pleurisy

2.8

11.7

216

N06AB10

ATC

escitalopram; oral

1.4

11.7

590

4412

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

11.7

120

601

K07

ICPC

Swollen ankles/oedema

2.0

11.7

133

691

ZXA10

NOMESCO Finland

Bilateral

1.4

11.7

538

3962

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

11.7

474

3412

J01CA02

ATC

pivampicillin; oral

2.2

11.7

410

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

11.7

211

1266

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

11.6

640

4857

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.5

11.6

R03AC19

ATC

olodaterol

19.0

11.6

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

11.6

191

1117

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.4

11.5

312

UDM02

NOMESCO Finland

Sinoscopy

2.6

11.5

241

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

11.5

253

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

11.5

173

985

SPAT1097

SPAT

Recording of ECG

1.5

11.5

421

2973

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

11.5

375

Z51.6

ICD-10 Finland

Desensitization to allergens

4.3

11.5

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

11.4

174

994

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

11.4

122

621

M54.2

ICD-10 Finland

Cervicalgia

1.6

11.4

237

1475

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.1

11.4

111

547

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.4

1955

17284

N03AX09

ATC

lamotrigine; oral

1.9

11.3

136

721

R21

ICPC

Throat symptom/complaint

1.4

11.3

554

4125

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

35.1

11.3

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.3

11.2

125

D07AC13

ATC

mometasone; topical

1.3

11.1

868

6945

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

3.0

11.1

162

C09CA01

ATC

losartan; oral

1.3

11.1

769

6047

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

11.1

126

656

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

3.2

11.1

131

R05CA10

ATC

expectorants - combinations

2.6

11.1

252

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

11.1

239

1502

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

11.0

194

1155

78330

ICD-8 Finland

Symptoms referable to respiratory system, Cough

11.2

11.0

M10.9

ICD-10 Finland

Gout, unspecified

1.7

11.0

204

1232

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.0

618

4706

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

10.9

187

1105

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

10.9

155

867

N06AX05

ATC

trazodone; oral

2.3

10.9

339

A12BA01

ATC

potassium chloride; oral

1.8

10.9

150

832

A10AB05

ATC

insulin aspart; parenteral

1.6

10.9

238

1501

SPAT1104

SPAT

Monitoring of emergency patient

1.7

10.9

195

1168

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

10.8

326

2211

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

10.8

181

1063

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

3.4

10.8

113

M01AX17

ATC

nimesulide; oral

1.3

10.8

717

5599

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.3

10.8

123

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

10.7

478

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

10.7

465

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

10.7

1071

8852

4122

FHL

Tympanostomy (tympanic tube)

3.0

10.7

155

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.7

486

3571

XF402

NOMESCO Finland

ECG with work load test

1.5

10.7

301

2014

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

10.6

196

1183

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

10.6

356

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.5

10.6

100

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

10.5

2305

20865

B37.08

ICD-10 Finland

Other candidal stomatitis

4.2

10.5

N03AE01

ATC

clonazepam; systemic

1.8

10.5

167

966

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

10.5

258

1672

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.4

10.5

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

4.4

10.5

C08DB01

ATC

diltiazem; oral

1.8

10.5

166

960

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

10.5

119

620

SPAT1360

SPAT

Extensive global examination

1.7

10.4

194

1173

R03DX07

ATC

roflumilast; oral

+∞

10.4

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

10.4

266

R06AX26

ATC

fexofenadine; oral

1.7

10.4

172

1008

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

10.4

261

1702

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

10.3

150

845

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

10.3

384

2717

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

4.2

10.3

N17

ICPC

Vertigo/dizziness

1.5

10.3

339

2341

A08

ICPC

Swelling

1.8

10.3

141

781

A29

ICPC

General symptom/complaint other

1.5

10.2

357

2497

P29

ICPC

Psychological sympt/compl other

1.7

10.2

184

1104

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

10.2

371

2616

B01AC04

ATC

clopidogrel; oral

1.4

10.2

477

3522

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

10.1

687

5377

A11

ICPC

Chest pain NOS

1.6

10.1

236

1511

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

10.1

109

557

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

10.1

158

910

A10BJ06

ATC

semaglutide; parenteral

1.8

10.1

139

771

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

10.1

332

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

10.1

198

1215

Y96.9

ICD-10 Finland

Unspecified type of accident

2.5

10.1

240

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

10.1

163

949

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

5.0

10.0

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

10.0

651

5062

S22.3

ICD-10 Finland

Fracture of rib

1.6

10.0

216

1357

C08CA01

ATC

amlodipine; oral

1.3

10.0

1176

9896

B01AB05

ATC

enoxaparin; parenteral

1.3

10.0

911

7425

WX722

NOMESCO Finland

PEEP

1.9

10.0

130

708

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

9.1

10.0

48499

ICD-8 Finland

Acute interstitial pneumonia

14.6

10.0

S76

ICPC

Skin infection other

1.8

10.0

150

855

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.0

509

3812

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

9.9

538

4067

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

9.9

278

C10AA01

ATC

simvastatin; oral

1.3

9.9

1285

10938

A10AE04

ATC

insulin glargine; parenteral

1.5

9.9

292

1972

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

9.9

120

639

SPAT1252

SPAT

Overall medication plan or its review

1.7

9.9

195

1198

J01AA04

ATC

lymecycline; systemic

1.5

9.9

364

2572

M02AA10

ATC

ketoprofen; topical

1.4

9.8

472

3497

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

9.8

790

6331

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.5

9.8

255

N05CF02

ATC

zolpidem; oral

1.4

9.8

501

3751

M05BA04

ATC

alendronic acid; oral

1.6

9.8

241

1563

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.9

9.8

152

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

9.7

109

565

M01AB51

ATC

indometacin, combinations; oral, rectal

2.3

9.7

331

R35

ICD-10 Finland

Polyuria

1.7

9.7

195

1204

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

9.7

156

907

L15

ICPC

Knee symptom/complaint

1.3

9.7

654

5113

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

9.7

237

1536

H02AB09

ATC

hydrocortisone; systemic

2.3

9.7

294

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

9.6

295

2009

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

9.6

138

776

M79.7

ICD-10 Finland

Fibromyalgia

2.2

9.6

346

N30.0

ICD-10 Finland

Acute cystitis

1.4

9.6

439

3227

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

8.4

9.5

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

9.5

286

1939

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

3.0

9.5

133

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

9.5

174

1048

P03

ICPC

Feeling depressed

1.6

9.5

238

1550

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

9.5

321

2229

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

7.1

9.5

A07DA03

ATC

loperamide; oral

2.0

9.5

102

522

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

9.4

132

736

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.5

9.4

242

F34.1

ICD-10 Finland

Dysthymia

2.0

9.4

475

Z50.1

ICD-10 Finland

Other physical therapy

1.7

9.4

152

885

R03BB05

ATC

aclidinium bromide; inhalant

30.1

9.4

E000006, ,

ATC

1.7

9.4

178

1083

R00.2

ICD-10 Finland

Palpitations

1.6

9.4

208

1317

SPAT1234

SPAT

Support of social functional capacity

1.7

9.3

162

962

A10BH01

ATC

sitagliptin; oral

1.5

9.3

271

1824

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

9.3

244

1605

S29

ICPC

Skin symptom/complaint other

1.4

9.3

530

4035

L12

ICPC

Hand/finger symptom/complaint

1.4

9.3

434

3199

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

9.3

138

785

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

9.2

275

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

9.2

130

727

EB1VA, ,

NOMESCO Finland

1.4

9.2

350

2487

N05AA02

ATC

levomepromazine; systemic

1.8

9.2

124

684

J01MA06

ATC

norfloxacin; oral

1.4

9.2

385

2785

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

9.2

493

ACC51

NOMESCO Finland

Release of median nerve

1.6

9.2

204

1292

GD1AA, ,

SPAT

1.5

9.2

335

2362

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.5

9.2

207

Kela drug reimbursment

Chronic arrhythmias

1.4

9.2

446

3311

R03

ICPC

Wheezing

3.4

9.2

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.6

9.1

204

Y1202

ICD-8 Finland

Skin tests, Allergy tests

7.7

9.1

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

9.1

127

708

J32

ICD-10 Finland

Chronic sinusitis

3.6

9.1

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

4.8

9.1

Z3231

NOMESCO Finland

Registered nurse

1.3

9.0

778

6286

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

9.0

123

681

N07BB01

ATC

disulfiram; oral

1.8

9.0

132

747

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

9.0

395

Z00.0

ICD-10 Finland

General medical examination

1.3

9.0

551

4245

A02BC04

ATC

rabeprazole; oral

1.5

9.0

240

1588

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

8.9

112

604

SPAT1153

SPAT

Removal of sutures

1.3

8.9

915

7557

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

8.9

431

3196

R83

ICPC

Respiratory infection other

1.3

8.9

702

5604

R33

ICD-10 Finland

Retention of urine

1.5

8.9

236

1558

XQ802

NOMESCO Finland

Epicutan test

1.9

8.9

100

520

Z71.8

ICD-10 Finland

Other specified counselling

1.3

8.9

859

7043

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

8.9

404

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

8.8

281

1929

M01AH05

ATC

etoricoxib; oral

1.2

8.8

1956

17579

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

8.8

120

665

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.8

631

4973

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.8

8.8

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

8.8

249

1669

WX892

NOMESCO Finland

Monitored bed care

1.6

8.8

207

1331

N07CA01

ATC

betahistine; oral

1.6

8.8

216

1403

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

8.7

197

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

8.7

270

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.1

8.7

354

GX1C5, ,

SPAT

14.0

8.7

J01GB01

ATC

tobramycin; inhalant, parenteral

50.1

8.7

XA402

NOMESCO Finland

ENMG

2.2

8.7

341

J96.0

ICD-10 Finland

Acute respiratory failure

3.1

8.7

114

J98.1

ICD-10 Finland

Pulmonary collapse

6.6

8.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

8.6

185

1162

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

8.6

395

WW200

NOMESCO Finland

Immunization

2.1

8.6

375

R52.0

ICD-10 Finland

Acute pain

2.0

8.6

484

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.0

8.6

125

A03DA02

ATC

pitofenone and analgesics; systemic

2.3

8.6

278

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

4.6

8.6

A10AC01

ATC

insulin (human); parenteral

1.5

8.5

248

1670

C07AB02

ATC

metoprolol; systemic

1.3

8.5

626

4946

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

8.5

472

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

8.5

308

2169

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

8.5

160

973

50708

ICD-8 Finland

Hay fever, Alia definita

6.4

8.5

5191A

ICD-9 Finland

Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified

20.1

8.5

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

2.5

8.5

206

A10BG03

ATC

pioglitazone; oral

2.1

8.4

358

M84.0

ICD-10 Finland

Malunion of fracture

4.2

8.4

A06AC51

ATC

ispaghula, combinations; oral

1.8

8.4

131

755

D06

ICPC

Abdominal pain localized other

1.5

8.4

225

1489

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.9

8.4

102

545

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

8.4

196

1258

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.4

259

1768

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

8.4

124

705

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.7

8.3

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.7

8.3

J43.8

ICD-10 Finland

Other emphysema

+∞

8.3

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

8.3

388

2859

L04AA06

ATC

mycophenolic acid; systemic

2.4

8.3

232

A01AC01

ATC

triamcinolone; local oral

2.4

8.3

220

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.7

8.3

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.1

8.3

112

Y0399

ICD-8 Finland

Investigation of circulatory system

2.8

8.3

139

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

8.2

946

7908

M05BA07

ATC

risedronic acid; oral

2.0

8.2

436

N03AF01

ATC

carbamazepine; oral, rectal

1.7

8.2

148

889

K08.80

ICD-10 Finland

Toothache NOS

1.5

8.2

228

1521

N03AF02

ATC

oxcarbazepine; oral

1.9

8.2

486

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

8.2

325

2330

59010

ICD-8 Finland

Infections of kidney, Pyelonephritis

2.6

8.1

180

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.9

8.1

SPAT1167

SPAT

Insertion of urinary catheter

1.9

8.1

501

R10.0

ICD-10 Finland

Acute abdomen

1.9

8.1

480

N05AF03

ATC

chlorprothixene; systemic

2.1

8.1

337

W19

ICD-10 Finland

Unspecified fall

1.5

8.1

288

2022

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

8.1

451

3422

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

8.1

154

940

M35.7

ICD-10 Finland

Hypermobility syndrome

3.0

8.1

119

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.1

407

3040

1410

FHL

Laparoscopy

2.3

8.0

267

C08CA02

ATC

felodipine; oral

1.5

8.0

273

1899

IHZ05, ,

SPAT

2.0

8.0

406

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

8.0

525

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

8.0

274

1909

6453

FHL

Radical surgery of hemorrhoids

2.2

8.0

300

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

1.9

8.0

104

569

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

8.0

571

4495

J05AH02

ATC

oseltamivir; oral

4.3

7.9

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

7.9

176

1116

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

7.9

176

1116

N06AB05

ATC

paroxetine; oral

1.6

7.9

158

976

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

7.9

105

578

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

7.9

128

748

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

7.8

7.9

SPAT1284

SPAT

Extensive health certificate

2.1

7.8

362

L16

ICPC

Ankle symptom/complaint

1.4

7.8

288

2034

C10AC01

ATC

colestyramine; oral

2.1

7.8

342

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

7.8

326

2356

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

7.8

126

735

ZXA05

NOMESCO Finland

Left side

1.3

7.8

717

5832

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

7.8

167

1050

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

7.8

110

617

48199

ICD-8 Finland

Pneumococcal pneumonia

9.4

7.8

R99

ICPC

Respiratory disease other

2.4

7.8

221

R4110, ,

SPAT

1.5

7.8

218

1459

R55

ICD-10 Finland

Syncope and collapse

1.4

7.7

321

2318

L04AD02

ATC

tacrolimus; systemic

2.9

7.7

122

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.7

7.7

143

866

N06AA04

ATC

clomipramine; systemic

2.4

7.7

203

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

7.7

247

1698

30180

ICD-8 Finland

Personality disorders, Immatura

4.2

7.7

J94.9

ICD-10 Finland

Pleural condition, unspecified

4.2

7.7

L08

ICPC

Shoulder symptom/complaint

1.3

7.7

600

4775

49000, ,

ICD-8 Finland

45.1

7.7

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

7.7

293

2083

KMAK, ,

NOMESCO Finland

1.2

7.7

1580

14022

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

7.7

115

656

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

7.7

345

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

7.7

345

E66.0

ICD-10 Finland

Obesity due to excess calories

3.1

7.7

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

3.2

7.7

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

7.6

152

938

A99

ICPC

Disease/condition unspecnature/site

1.5

7.6

248

1711

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

7.6

161

1011

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

7.5

117

675

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

7.5

211

1411

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

7.5

609

4871

D11AH01

ATC

tacrolimus; topical

3.5

7.5

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

3.5

7.5

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.9

7.5

113

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.8

7.5

124

M54

ICD-10 Finland

Dorsalgia

1.4

7.5

336

2459

K08.3

ICD-10 Finland

Retained dental root

1.5

7.5

216

1453

SFA10

NOMESCO Finland

One-surface restoration

1.2

7.5

1661

14837

A10BJ02

ATC

liraglutide; parenteral

2.0

7.5

382

46209

ICD-8 Finland

Acute pharyngitis, Unspecified

3.0

7.5

108

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.7

7.5

147

X58

ICD-10 Finland

Exposure to other specified factors

1.4

7.5

409

3095

78880

ICD-8 Finland

Other general symptoms, Pyrexia of unknown origin

3.7

7.5

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.4

210

1407

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

7.4

257

GDC00

NOMESCO Finland

Lobectomy of lung

4.4

7.4

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

4.4

7.4

R04.0

ICD-10 Finland

Epistaxis

1.5

7.4

212

1425

L29

ICPC

Musculoskeletal sympt/complt other

1.5

7.4

223

1515

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

7.4

183

1191

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

7.4

468

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

7.4

194

1281

RS221, ,

NOMESCO Finland

2.6

7.3

160

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.3

1817

16394

P06

ICPC

Sleep disturbance

1.4

7.3

300

2163

R09.3

ICD-10 Finland

Abnormal sputum

2.9

7.3

115

R03DX09

ATC

mepolizumab; parenteral

+∞

7.3

3028

Kela drug reimbursment

Mepolizumab

+∞

7.3

297, ,

Kela drug reimbursment

+∞

7.3

UDC00

NOMESCO Finland

Ear microscopy

1.5

7.3

192

1268

WX002

NOMESCO Finland

Sedation and analgesia

1.3

7.2

529

4173

M05BA01

ATC

etidronic acid; systemic

3.8

7.2

-1, ,

NOMESCO Finland

1.2

7.2

937

7924

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

7.2

222

X01

ICPC

Genital pain female

3.3

7.2

R06.5

ICD-10 Finland

Mouth breathing

1.5

7.2

249

1738

R03DB04

ATC

theophylline and adrenergics; systemic

15.8

7.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

7.2

247

1722

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

2.7

7.2

144

M01AX01

ATC

nabumetone; oral

1.7

7.2

113

655

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.1

7.2

327

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

3.7

7.2

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

7.2

225

1542

5198X

ICD-9 Finland

Other diseases of respiratory system, not elsewhere classified

30.1

7.1

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.2

7.1

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

7.1

349

C08CA07

ATC

nisoldipine; oral

2.4

7.1

187

79399

ICD-8 Finland

Observation, without need for further medical care, Unspecified

2.7

7.1

134

H25.8

ICD-10 Finland

Other senile cataract

1.4

7.0

322

2366

I20.00

ICD-10 Finland

Unstable angina

1.9

7.0

476

S01

ICPC

Pain/tenderness of skin

1.7

7.0

112

652

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

10.0

7.0

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

7.0

257

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

2.9

7.0

107

R49.08

ICD-10 Finland

Other specified dysphonia

2.3

7.0

232

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.0

2216

20410

R51

ICD-10 Finland

Headache

1.6

7.0

137

844

R07

ICPC

Sneezing/nasal congestion

1.6

7.0

155

985

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

3.3

7.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

6.9

137

845

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.4

6.9

195

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

6.9

135

830

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.4

6.9

189

ZXD05

NOMESCO Finland

Urgent procedure

1.2

6.9

912

7723

RD210, ,

NOMESCO Finland

2.4

6.9

183

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

6.9

115

678

62200

ICD-8 Finland

Infective diseases of uterus (except cervix), vagina and vulva, Endometritis acuta

3.7

6.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.9

225

1554

K03.66

ICD-10 Finland

Tooth plaque

1.5

6.9

187

1243

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.8

6.9

552

G04CA02

ATC

tamsulosin; oral

1.3

6.9

720

5941

J01X

ATC

OTHER ANTIBACTERIALS

4.0

6.9

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.6

6.9

142

SPAT1283

SPAT

Restricted health certificate

1.3

6.9

420

3231

R12

ICD-10 Finland

Heartburn

1.5

6.9

207

1408

R07.1

ICD-10 Finland

Chest pain on breathing

2.4

6.8

190

212

Kela drug reimbursment

Gout

2.1

6.8

313

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

6.8

770

6408

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.5

6.8

172

D01

ICPC

Abdominal pain/cramps general

1.4

6.8

294

2139

-69

ICPC

Other reason for encounter NEC

1.8

6.8

100

569

TAB00

NOMESCO Finland

Lumbar puncture

1.7

6.8

120

719

P28

ICPC

Limited function/disability (P)

3.0

6.8

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

6.8

294

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.0

6.8

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.0

6.8

Q32.0

ICD-10 Finland

Congenital tracheomalacia

40.1

6.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

6.8

165

1072

Z2446

NOMESCO Finland

Social worker

1.6

6.8

168

1096

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

6.7

119

713

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.7

244

1720

N05BA02

ATC

chlordiazepoxide; systemic

2.0

6.7

342

S81.0

ICD-10 Finland

Open wound of knee

2.3

6.7

198

P99

ICPC

Psychological disorders other

1.9

6.7

391

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

6.7

249

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.6

6.7

138

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.6

6.7

138

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

6.7

289

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

6.7

158

1019

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

22.5

6.7

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

6.7

276

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

6.7

204

1392

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

6.7

135

839

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.6

356

2684

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

6.6

123

747

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

6.6

173

1141

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

6.6

114

679

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.6

6.6

153

982

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.4

6.6

181

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.4

6.6

169

N06AA10

ATC

nortriptyline; systemic

2.2

6.6

251

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.6

6.6

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.3

6.6

200

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

6.6

100

ZX120, ,

SPAT

2.8

6.6

111

127

Kela drug reimbursment

Transplant complication

2.3

6.6

194

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

6.5

166

1088

ZX120

NOMESCO Finland

Intravenous

1.4

6.5

251

1789

J05AB11

ATC

valaciclovir; oral

1.3

6.5

376

2866

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

6.5

353

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

2.5

6.5

152

L04AA01

ATC

[U] ciclosporin

2.5

6.5

158

205

Kela drug reimbursment

Chronic hypertension

1.2

6.5

838

7074

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.5

1016

8750

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

6.5

361

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

6.5

142

900

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

6.5

322

2400

P20

ICPC

Memory disturbance

1.3

6.5

369

2810

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.4

6.5

183

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

6.4

332

2488

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

6.4

141

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

6.4

301

2221

WX290

NOMESCO Finland

Other blockage of nerve

1.2

6.4

1368

12126

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

6.4

106

624

J01XB01

ATC

colistin; inhalant, parenteral

70.0

6.4

C09CA06

ATC

candesartan; oral

1.3

6.4

659

5423

Z08

ICPC

Social welfare problem

2.5

6.4

159

I20.09

ICD-10 Finland

Unstable angina

1.6

6.4

160

1045

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.2

6.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

6.4

117

708

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

6.4

462

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

6.4

149

958

A10BH02

ATC

vildagliptin; oral

2.1

6.4

274

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

6.4

109

648

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.0

6.4

308

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

6.4

1046

9047

D07XC01

ATC

betamethasone; topical

1.4

6.4

333

2501

N04BC05

ATC

pramipexole; oral

1.5

6.4

201

1380

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.7

6.4

105

618

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

6.4

162

1063

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

6.4

1011

8717

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

6.4

224

1572

J04.0

ICD-10 Finland

Acute laryngitis

1.9

6.3

406

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.0

6.3

343

AN4

Balloon angioplasty and drug eluding stent

1.8

6.3

522

S11

ICPC

Skin infection post-traumatic

2.5

6.3

154

Z01.2

ICD-10 Finland

Dental examination

1.2

6.3

1289

11376

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

6.3

545

P17

ICPC

Tobacco abuse

2.7

6.3

125

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.1

6.3

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

6.3

177

1187

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

6.3

167

1106

SPAT1060

SPAT

Administration of oxygen

5.9

6.3

J15

ICD-10 Finland

Bacterial pneumonia, not elsewhere classified

11.0

6.3

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

5.5

6.3

41291

ICD-8 Finland

Chronic ischaemic heart disease, Status post infarctum cordis, hypertonia non indicata

3.5

6.3

NHQ40

NOMESCO Finland

Amputation of toe

2.2

6.3

230

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

6.3

135

852

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

6.3

346

2621

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

18.0

6.3

78320

ICD-8 Finland

Symptoms referable to respiratory system, Tetania hyperventilatoria

18.0

6.3

A08AA02

ATC

fenfluramine; oral

2.9

6.3

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

6.3

324

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

6.2

R06AX11

ATC

astemizole; oral

1.9

6.2

380

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.2

429

3355

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

6.2

525

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

6.2

619

5074

U02

ICPC

Urinary frequency/urgency

1.3

6.2

347

2633

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.3

6.2

180

L30.3

ICD-10 Finland

Infective dermatitis

1.8

6.2

474

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

6.2

474

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

6.2

125

776

H01

ICPC

Ear pain/earache

1.4

6.2

268

1951

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.3

6.2

199

137

Kela drug reimbursment

Uraemia requiring dialysis

2.8

6.2

109

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.2

368

2819

Angiography of the heart and coronary arteries

1.5

6.2

170

1135

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

6.2

446

WZC30

NOMESCO Finland

Teaching

1.3

6.2

407

3165

J01CA08

ATC

pivmecillinam; oral

1.2

6.2

1065

9252

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.7

6.2

115

R49.03

ICD-10 Finland

Atrophic dysphonia

2.7

6.2

115

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

2.2

6.2

206

4140X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]

3.1

6.2

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

6.2

527

WX199

NOMESCO Finland

Other local analgesia

1.8

6.2

527

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

6.3

6.2

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

6.1

166

1104

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.1

2040

18767

Z29

ICPC

Social problem NOS

2.0

6.1

299

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.1

6.1

272

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.3

6.1

U71

ICPC

Cystitis/urinary infection other

1.5

6.1

153

1001

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

6.1

136

866

H57.1

ICD-10 Finland

Ocular pain

1.8

6.1

521

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

6.1

166

1106

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

6.1

180

1220

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.0

6.1

293

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.7

6.1

114

695

N71.9

ICD-10 Finland

Inflammatory disease of uterus, unspecified

4.1

6.1

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

4.1

6.1

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.1

6.1

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

6.1

115

703

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.8

6.1

1243

FHL

Bronchoscopy and other therapeutic procedure

12.5

6.1

D06AX01

ATC

fusidic acid; topical

1.4

6.1

259

1882

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.8

6.1

507

56109

ICD-8 Finland

Gastro-enteritis and colitis, except ulcerative, of non-infectious origin, Unspecified

3.0

6.1

L04AA13

ATC

[U] leflunomide

2.0

6.1

321

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.1

141

907

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.1

1113

9723

R01BA01

ATC

phenylpropanolamine; oral

1.6

6.1

133

844

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.1

6.1

260

Y60

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.8

6.0

105

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.0

442

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

6.0

213

1496

30399

ICD-8 Finland

Other and unspecified alcoholism

6.7

6.0

Z3226

NOMESCO Finland

Physiotherapist

1.3

6.0

483

3856

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.9

6.0

385

XKC03

NOMESCO Finland

Water cystometry

1.8

6.0

421

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.0

475

3785

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

6.0

472

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023419) Bacteria identified in Sputum by Culture

168

185

9.44

139.08

4.1

1.6

—

(4200892) Spirometry reversibility

411

1270

3.50

109.42

1.5

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

382

1129

3.64

108.83

1.6

1.1

270.49

210.08

u/ml

0.65

360

1026

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

13.88

93.88

1.4

1.1

1.50

1.09

u/ml

0.30

(3013115) Eosinophils [#/volume] in Blood

1977

14337

1.77

64.42

7.3

6.0

0.21

0.19

e9/l

6.62

1778

12488

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

778

4298

2.01

59.90

2.3

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

1813

13088

1.72

57.80

7.6

5.9

2.96

2.80

1.94

1705

12192

(3022096) Basophils/100 leukocytes in Blood

1763

12651

1.72

57.28

7.7

6.0

0.65

0.67

0.84

1657

11757

(3019069) Monocytes/100 leukocytes in Blood

1817

13165

1.71

56.82

8.2

6.2

8.60

8.70

0.66

1714

12285

(40760892) CBC W Ordered Manual Differential panel - Blood

1796

13004

1.70

56.05

7.5

6.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

379

1604

2.51

55.86

4.5

3.1

5.24

5.10

kpa

2.14

361

1501

(3006315) Basophils [#/volume] in Blood

1894

13926

1.70

55.69

7.1

5.7

0.04

e9/l

1.77

1697

11982

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

224

717

3.25

55.61

3.5

2.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

1851

13591

1.69

54.19

7.8

6.0

27.14

28.00

2.69

1748

12725

(3019198) Lymphocytes [#/volume] in Blood

1934

14368

1.68

54.13

7.3

5.8

1.93

1.92

e9/l

0.04

1762

12648

(3023368) Bacteria identified in Blood by Culture

1171

7584

1.78

54.12

5.5

4.2

—

(3001604) Monocytes [#/volume] in Blood

1884

13903

1.68

54.07

7.1

5.7

0.63

0.58

e9/l

11.50

1688

11968

(3018010) Neutrophils/100 leukocytes in Blood

1823

13375

1.68

53.18

7.5

5.8

57.90

57.19

1.74

1714

12498

(3009343) pH of Capillary blood

370

1587

2.47

52.90

4.5

3.1

7.41

0.15

179

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

960

6005

1.79

49.17

1.9

1.8

1.12

1.26

mg/l

0.79

749

4548

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1175

7810

1.72

48.52

3.6

2.9

1498.33

1525.63

ng/l

0.07

1021

6606

(3000492) Spirometry study

458

2248

2.17

47.59

1.5

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

348

1530

2.40

46.96

4.5

3.1

1.81

1.58

mmol/l

0.56

265

1083

(3022217) INR in Platelet poor plasma by Coagulation assay

1774

13398

1.59

42.77

16.8

15.3

1.25

1.29

inr

1.00

523

3855

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1506

10942

1.61

42.71

4.7

3.4

42.37

104.41

ng/l

0.82

1064

7446

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1267

8870

1.63

41.55

2.9

2.5

52.53

67.94

u/l

1.04

1168

8178

(3013650) Neutrophils [#/volume] in Blood by Automated count

2072

16313

1.57

41.13

9.9

9.0

4.42

4.06

e9/l

8.85

1859

14142

(3013707) Erythrocyte sedimentation rate by Westergren method

2555

21224

1.59

39.25

5.0

3.8

13.32

11.61

mm/h

6.39

2370

19605

(3022313) Gas panel - Capillary blood

274

1182

2.42

38.41

4.5

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

560

3219

1.86

36.74

2.0

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2118

17028

1.53

36.28

5.8

4.6

6.84

6.76

mmol/l

0.87

2028

15897

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

173

4.76

35.49

3.9

3.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1884

14829

1.52

35.24

6.6

6.2

10.44

12.02

umol/l

9.32

1779

14040

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1787

13960

1.52

34.31

8.2

6.7

1.21

mmol/l

0.30

1544

11838

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

262

1168

2.33

34.04

2.5

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

235

3.94

31.25

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

239

1068

2.32

30.86

2.1

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

234

1039

2.33

30.66

4.8

3.2

25.04

24.76

mmol/l

0.82

216

944

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1186

8671

1.53

30.10

2.4

2.1

195.15

241.14

u/l

0.94

1111

8129

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

821

5550

1.61

29.33

4.9

3.5

565.77

481.45

ng/l

0.12

624

4320

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

313

1598

2.04

28.85

1.9

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

172

689

2.56

28.21

1.4

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

369

2032

1.90

27.29

3.1

2.6

10.21

10.72

g/l

1.59

345

1848

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

486

2913

1.76

27.27

2.2

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

486

2922

1.76

26.97

2.3

1.6

—

(3042631) Mycobacterium sp identified in Specimen

266

3.48

26.13

3.5

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

352

1943

1.89

25.80

1.8

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1247

9444

1.47

25.76

3.6

3.2

30.18

36.99

u/l

2.98

1184

8947

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1586

12580

1.44

25.60

7.1

6.0

1.21

mmol/l

0.08

1444

11445

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1469

11532

1.44

24.88

2.5

2.2

76.62

76.83

nmol/l

0.10

1305

10345

(3026008) Bacteria identified in Urine by Culture

1113

8344

1.47

23.84

3.7

3.1

—

(3042936) Bacteria identified in Isolate by Culture

602

3950

1.62

23.83

2.4

2.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

227

1105

2.12

23.72

1.6

21.23

17.66

u/ml

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

110

385

2.91

23.44

2.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

110

385

2.91

23.44

2.2

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2219

18868

1.41

23.27

5.9

4.3

1710.92

1873.64

e6/l

0.07

266

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.63

23.01

4.9

3.1

—

(3000494) Fungus identified in Specimen by Culture

498

3149

1.67

22.77

1.8

1.4

—

(3013512) EKG study

1104

8338

1.45

22.50

5.0

3.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

387

2300

1.76

22.18

3.8

2.8

195.40

214.96

ng/l

0.37

341

2074

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2567

22512

1.41

21.66

8.9

7.2

76.53

78.29

u/l

1.46

2429

21174

(3004789) Transferrin [Mass/volume] in Serum or Plasma

610

4105

1.58

21.55

2.9

2.4

2.35

2.31

g/l

1.02

550

3797

(3037467) Urinalysis macro (dipstick) panel - Urine

2321

20020

1.39

21.54

5.5

4.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

290

1593

1.89

21.51

1.8

1.9

1.23

1.38

g/l

0.69

265

1458

(3019225) pH of Specimen

450

2811

1.68

21.50

5.0

4.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

160

709

2.31

21.08

1.6

1.3

14.13

9.00

iu/ml

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1023

7697

1.45

21.02

3.0

2.6

4345.61

5229.80

umol/l

0.28

897

6772

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

5.52

21.00

1.2

1.1

10.70

9.87

u/ml

—

(3017732) Neutrophils [#/volume] in Blood

334

1940

1.79

20.68

3.3

2.7

4.33

5.40

e9/l

1.48

256

1579

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

4.34

20.59

2.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

4.34

20.59

2.4

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

573

3841

1.58

20.51

3.1

2.5

21.55

23.69

2.97

488

3290

(3024139) IgG subclass 3 [Mass/volume] in Serum

223

3.36

20.33

1.5

1.3

0.40

0.41

g/l

0.10

151

(3028192) IgG subclass 2 [Mass/volume] in Serum

223

3.36

20.33

1.5

1.3

2.86

2.99

g/l

0.33

150

(3027135) IgG subclass 1 [Mass/volume] in Serum

224

3.35

20.19

1.5

1.3

6.49

7.03

g/l

0.73

152

(3022948) Iron [Moles/volume] in Serum or Plasma

644

4446

1.54

20.19

3.0

2.4

12.49

13.50

umol/l

2.93

586

4136

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

150

660

2.32

20.09

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

103

382

2.74

19.76

1.2

1.1

1.72

2.29

u/ml

0.28

164

(3003888) Timothy IgE Ab [Units/volume] in Serum

351

2.81

19.50

1.1

4.84

5.66

u/ml

0.21

159

(4062490) Immunoglobulin typing, IgG

225

3.29

19.37

1.6

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

818

5980

1.46

19.32

3.4

2.5

5.14

5.19

e6/l

0.05

738

5354

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

947

7119

1.44

19.27

2.7

2.1

3.18

2.90

mg/l

2.04

809

6016

(3010726) Horse dander IgE Ab [Units/volume] in Serum

310

2.91

19.19

1.1

1.0

1.87

1.49

u/ml

0.25

127

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

131

567

2.36

18.25

2.0

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

180

888

2.08

18.18

2.0

1.5

151.43

343.68

titre

—

(3007164) IgA [Mass/volume] in Serum or Plasma

727

5262

1.47

17.92

1.6

1.5

2.43

2.44

g/l

0.03

482

3287

(3024561) Albumin [Mass/volume] in Serum or Plasma

1507

12363

1.36

17.88

5.1

4.8

35.32

35.69

g/l

1.71

1392

11517

(3003396) Base excess in Arterial blood by calculation

462

3038

1.59

17.82

7.3

7.7

1.46

0.77

mmol/l

3.74

375

2368

(3008401) Mugwort IgE Ab [Units/volume] in Serum

342

2.73

17.61

1.1

1.0

1.05

1.55

u/ml

0.30

115

(3012095) Magnesium [Moles/volume] in Serum or Plasma

639

4523

1.49

17.60

4.1

3.3

0.81

0.82

mmol/l

0.75

587

4239

(40768797) Stomach Pathology biopsy report

538

3697

1.53

17.03

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

729

5331

1.45

16.94

1.8

1.7

1072.72

1151.99

nmol/l

1.44

532

3993

(3047007) Chlamydophila sp Ab [Presence] in Serum

363

2.63

16.71

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

529

3638

1.52

16.66

1.4

1.3

456.94

527.87

titre

0.52

111

747

(3002582) Erythrocytes [#/volume] in Urine

1107

8731

1.37

16.59

4.1

3.1

110.93

106.94

e6/l

0.02

892

6681

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

628

4478

1.48

16.59

1.3

29.96

32.02

iu/ml

0.18

200

1426

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

3.22

16.52

2.2

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

3.22

16.52

2.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

3.22

16.52

2.2

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

455

3037

1.56

16.40

7.3

7.7

11.15

12.88

kpa

11.91

430

2888

(3021960) Folate [Moles/volume] in Serum or Plasma

851

6434

1.41

16.40

1.7

1.5

19.91

20.40

nmol/l

0.41

720

5501

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

455

3039

1.56

16.35

7.4

7.7

5.15

5.03

kpa

1.96

431

2890

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

3.47

16.03

1.3

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

271

1600

1.75

15.82

1.7

1.4

—

(3016502) Oxygen saturation in Arterial blood

410

2709

1.57

15.41

7.5

8.2

94.54

95.92

3.06

393

2609

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2282

20168

1.32

15.14

3.8

3.0

52.05

49.31

u/l

0.66

2131

18863

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

593

4256

1.46

15.05

1.3

1.2

21.57

12.51

u/ml

0.55

212

1680

(3018095) Leukocytes [#/volume] in Urine

1247

10152

1.33

14.85

4.7

3.5

104.90

103.50

e6/l

0.02

950

7181

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

387

2.46

14.69

1.5

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

469

3236

1.51

14.45

4.3

4.4

232.82

247.91

u/l

1.94

437

3042

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1460

12196

1.31

14.38

3.4

2.7

128.68

140.02

ug/l

0.75

1345

11274

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2144

18863

1.30

14.32

3.4

2.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1407

11703

1.32

14.26

2.2

1.9

94.99

95.37

pmol/l

0.10

755

6107

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

258

2.78

14.25

2.5

1.6

—

(3019060) Gas panel - Arterial blood

272

1655

1.69

14.23

5.1

—

(3021901) Oxygen saturation in Capillary blood

100

433

2.34

14.00

3.3

2.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

118

548

2.19

13.99

2.3

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

235

1384

1.74

13.84

7.9

10.5

24.58

24.09

mmol/l

1.54

221

1336

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

531

3789

1.46

13.81

1.8

1.56

1.47

1.59

464

3363

(3027945) Reticulocytes/100 erythrocytes in Blood

456

3162

1.50

13.69

3.3

2.5

1.73

1.75

0.18

390

2776

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3205

29940

1.39

13.55

21.7

13.0

24.32

24.43

mg/l

0.07

2752

23342

(3030981) Hyaline casts [#/volume] in Urine by Automated count

249

1504

1.70

13.39

3.8

2.7

0.37

0.30

e6/l

0.24

244

1465

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

533

2.17

13.31

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

533

2.17

13.31

1.4

1.2

—

(3011412) CD3 cells [#/volume] in Blood

260

2.68

12.96

2.6

2.5

1.29

1.17

e9/l

0.52

226

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

238

2.76

12.90

2.6

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

344

2.44

12.83

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

195

1113

1.79

12.81

2.4

2.0

3.73

2.71

ug/l

0.21

164

983

(3020630) Protein [Mass/volume] in Serum or Plasma

345

2287

1.56

12.74

2.4

2.6

66.63

66.53

g/l

0.08

309

2079

(3014133) Dog dander IgE Ab [Units/volume] in Serum

274

2.62

12.73

1.1

1.0

5.65

1.38

u/ml

1.66

113

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

180

3.03

12.69

2.5

2.6

647.15

508.57

e6/l

0.92

142

(3036481) Cortisol [Moles/volume] in Serum or Plasma

367

2478

1.53

12.47

2.1

339.07

379.54

nmol/l

3.85

331

2272

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

776

6016

1.36

12.43

1.8

1.6

47115808.86

36663759.74

pmol/l

0.19

624

5005

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

302

2.51

12.34

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

373

2533

1.52

12.33

2.6

2.3

7.82

8.16

ug/l

0.07

307

2206

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.86

12.33

3.0

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

377

2570

1.52

12.24

5.5

3.8

5.94

5.76

kpa

2.36

366

2494

(3014111) Lactate [Moles/volume] in Serum or Plasma

362

2447

1.53

12.23

7.2

7.3

1.41

1.39

mmol/l

0.11

349

2373

(3025018) Bordetella pertussis Ab [Titer] in Serum

138

3.29

12.15

1.4

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

103

480

2.18

12.15

1.9

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

306

2.48

12.01

1.3

1.4

—

(3002032) Base excess in Venous blood by calculation

374

2559

1.51

11.93

5.5

3.8

2.28

1.80

mmol/l

1.82

325

2136

(3023430) Cat dander IgE Ab [Units/volume] in Serum

256

2.60

11.74

1.0

7.16

3.26

u/ml

0.74

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.79

11.71

3.0

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.79

11.71

3.0

2.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

367

2.32

11.58

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

11.10

11.52

1.1

1.2

37.95

23.90

mg/l

0.62

(3003458) Phosphate [Moles/volume] in Serum or Plasma

503

3671

1.42

11.49

7.6

6.0

1.05

1.03

mmol/l

1.22

462

3413

(3024980) IgG subclass 4 [Mass/volume] in Serum

395

2.26

11.40

1.6

0.92

0.80

g/l

0.22

298

(3022621) pH of Urine by Test strip

293

1922

1.57

11.33

3.5

3.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

171

2.95

11.28

2.7

0.21

0.23

e9/l

0.15

141

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

486

3540

1.43

11.22

4.8

4.3

32.04

31.85

0.14

338

2427

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

152

838

1.85

11.21

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

763

5998

1.34

11.01

1.3

1.2

1.88

1.70

u/ml

0.09

200

1603

(3015377) Calcium [Moles/volume] in Serum or Plasma

1145

9520

1.29

10.95

3.2

3.4

2.35

mmol/l

0.86

973

8370

(3048689) Calprotectin [Mass/mass] in Stool

454

3287

1.43

10.82

2.4

132.85

131.84

ug/g

0.03

363

2634

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2416

21969

1.26

10.72

4.2

3.7

14.79

14.75

pmol/l

0.36

2215

19973

(3020682) Albumin/Creatinine [Ratio] in Urine

1060

8750

1.29

10.67

4.1

3.8

14.21

8.72

mg/mmol

1.68

665

5640

(3030467) Casts [#/volume] in Urine by Automated count

971

7937

1.30

10.52

4.0

3.0

0.32

0.43

e6/l

1.47

768

6023

(3044640) Blood type and Crossmatch panel - Blood

1112

9253

1.28

10.48

3.0

2.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

340

2.29

10.40

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

334

2.30

10.38

1.7

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

128

687

1.89

10.29

2.2

2.0

10.76

12.26

mg/l

0.92

122

635

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

168

982

1.74

10.22

2.5

327.56

751.27

ug/l

1.23

157

929

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

331

2.29

10.15

1.8

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

331

2.29

10.15

1.8

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

150

2.95

10.02

1.2

1.0

12.46

10.79

iu/ml

—

(3025941) Bacteria identified in Stool by Culture

244

1581

1.58

9.96

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

400

2.15

9.86

1.2

1.1

8.44

9.86

au/ml

—

(3009508) Creatinine [Moles/volume] in Urine

1069

8925

1.27

9.66

3.6

3.2

7.42

7.90

mmol/l

2.91

894

7530

(3017181) Myelocytes/100 leukocytes in Blood

321

2226

1.48

9.58

4.6

4.3

0.87

0.90

0.07

121

783

(3025468) Yersinia sp identified in Specimen by Organism specific culture

330

2.23

9.37

1.8

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

337

2.22

9.33

1.8

1.4

—

(3026782) Osmolality of Urine

725

5780

1.31

9.33

3.6

2.8

528.01

552.14

mosm/kgh2o

2.18

633

4966

(36304419) Bacteria [Presence] in Urine

943

7791

1.28

9.21

3.8

2.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

410

2.07

8.90

2.1

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

570

4420

1.34

8.88

2.6

2.2

30.18

29.93

0.42

551

4280

(3019977) pH of Arterial blood

123

3.03

8.83

2.3

2.6

7.43

7.42

—

(3012516) Albumin [Mass/volume] in Urine

991

8307

1.26

8.47

3.5

3.3

317.10

347.55

mg/l

0.08

647

5369

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.17

8.44

1.2

1.1

2.90

2.16

u/ml

0.11

(3020779) Urea [Moles/volume] in Serum or Plasma

352

2546

1.42

8.41

10.1

7.6

10.17

9.92

mmol/l

0.27

339

2419

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

352

2.12

8.41

1.1

1.53

1.52

g/l

0.07

320

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

178

1115

1.62

8.41

4.6

5.3

1.82

1.59

1.19

167

1043

(3023520) Reticulocytes [#/volume] in Blood

327

2334

1.44

8.40

2.7

2.6

70.54

68.46

e9/l

0.56

257

1763

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

580

4545

1.32

8.38

3.4

2.8

2.83

2.33

e6/l

0.61

341

2463

(3021440) Promyelocytes/100 leukocytes in Blood

300

2109

1.46

8.36

4.6

4.4

0.15

0.12

0.32

102

666

(3008536) Aspergillus sp Ab [Presence] in Serum

4.88

8.35

2.7

2.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

291

2035

1.46

8.33

5.0

4.0

113.96

92.66

ng/l

1.96

247

1750

(3025159) Blasts/100 leukocytes in Blood

285

1987

1.47

8.29

4.4

0.06

0.29

0.90

558

(3000475) Leukocytes [#/volume] in Synovial fluid

116

649

1.81

8.26

1.6

1.7

17236.03

15163.47

e6/l

0.18

469

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

108

591

1.85

8.25

1.6

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

290

2033

1.46

8.20

4.3

4.1

0.54

0.71

0.85

109

681

(3027273) Bicarbonate [Moles/volume] in Venous blood

206

1345

1.56

8.18

4.4

3.3

25.45

25.05

mmol/l

0.80

199

1305

(3000991) Gas panel - Venous blood

316

2254

1.44

8.15

9.7

8.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

101

545

1.88

8.07

2.1

2.0

128.99

129.99

g/l

0.16

396

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.64

8.00

1.6

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

268

1863

1.47

7.92

2.3

2.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

265

2.24

7.75

2.0

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

265

2.24

7.75

2.0

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

378

2.03

7.71

1.9

2.0

480.00

1094.55

titre

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

285

2.19

7.71

4.6

4.5

—

(3018418) pH of Serum or Plasma

970

8190

1.24

7.66

4.8

4.0

7.39

7.40

0.65

163

1567

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

219

1472

1.52

7.64

2.3

2.4

—

(40758558) Short blood count panel - Blood

860

7168

1.26

7.61

8.4

6.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

193

2.45

7.56

2.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

167

1059

1.60

7.54

1.8

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

167

1060

1.60

7.51

1.8

2.3

7.02

7.30

g/l

1.28

146

945

(3035350) Ketones [Presence] in Urine by Test strip

1578

14032

1.21

7.47

4.2

3.5

0.00

estimate

0.12

308

2750

(3004616) Nuclear Ab [Presence] in Serum

316

2.11

7.42

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

246

2.25

7.32

1.0

1.03

0.49

u/ml

0.32

(3020874) Milk IgE Ab [Units/volume] in Serum

126

2.79

7.31

1.1

1.0

0.63

0.49

u/ml

0.20

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

128

768

1.69

7.19

2.0

2.3

0.02

0.01

g/l

0.08

117

699

(3021601) Nitrite [Presence] in Urine by Test strip

1570

13993

1.20

7.16

5.9

4.8

0.00

estimate

0.50

284

2581

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

846

7083

1.25

7.15

3.0

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1058

1.58

7.13

1.8

2.3

3.50

3.65

g/l

0.84

145

945

(3022145) Colonoscopy Study observation

405

3087

1.35

7.04

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

171

1110

1.57

7.01

4.7

5.3

0.88

0.89

0.22

160

1040

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

123

737

1.69

6.96

2.0

1.6

0.22

0.23

g/l

0.64

110

694

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

156

993

1.59

6.96

1.9

2.4

2.86

2.92

g/l

0.25

136

880

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

601

4847

1.28

6.94

3.2

2.6

1.34

1.20

e6/l

0.16

364

2740

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

352

2.01

6.93

6.9

6.7

11.20

11.64

mg/l

0.35

328

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

143

892

1.63

6.93

2.0

2.4

0.62

0.98

g/l

0.87

125

754

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.70

6.90

2.0

1.4

0.32

0.40

ug/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

523

1.82

6.88

1.5

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2848

26881

1.22

6.80

5.1

4.4

2.80

2.15

mu/l

0.44

2624

24596

(40768804) Tissue Pathology biopsy report

1312

11539

1.21

6.80

2.2

2.1

—

(3000330) Specific gravity of Urine by Test strip

214

1468

1.48

6.80

4.3

3.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

909

7712

1.23

6.75

4.1

3.2

—

(3028433) Virus identified in Specimen by Culture

3.22

6.69

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

1580

14155

1.19

6.66

4.3

3.6

0.00

0.01

estimate

0.16

263

2484

(3008152) Bicarbonate [Moles/volume] in Arterial blood

238

1675

1.45

6.63

8.5

7.0

24.95

24.24

mmol/l

2.06

227

1591

(1616796) Gas panel - Central venous blood

545

1.78

6.59

3.0

3.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2890

27346

1.22

6.58

6.6

5.4

40.67

39.70

mmol/mol

4.50

2678

25353

(3002173) Hemoglobin [Mass/volume] in Arterial blood

339

2545

1.36

6.50

8.6

122.22

121.30

g/l

0.35

328

2479

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

605

4928

1.27

6.43

1.6

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

171

1135

1.53

6.38

2.2

1.9

37.98

39.52

u/l

0.51

158

995

(3040151) Glucose [Moles/volume] in Capillary blood

302

2.04

6.33

7.5

5.5

7.17

7.28

mmol/l

0.11

248

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2971

28229

1.22

6.29

17.5

12.4

81.07

81.82

ml/min/173m2

1.04

2524

23344

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

134

845

1.61

6.25

2.5

3.6

35.01

54.21

mg/l

1.18

111

683

(3017354) Segmented neutrophils/100 leukocytes in Blood

277

2.07

6.23

3.5

3.7

56.72

55.50

0.14

234

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

148

958

1.57

6.18

5.6

3.5

0.35

0.33

u/ml

0.19

557

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.97

6.16

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.97

6.16

1.5

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

134

849

1.60

6.13

2.5

3.6

59.05

64.06

mg/l

0.12

109

687

(3024354) Oxygen [Partial pressure] in Venous blood

289

2136

1.38

6.12

4.9

3.1

4.99

4.63

kpa

1.19

278

2066

(3015736) pH of Urine

1280

11322

1.19

6.08

3.9

3.3

5.72

5.84

0.75

919

(3047181) Lactate [Moles/volume] in Blood

134

851

1.59

6.08

5.7

6.1

1.41

1.31

mmol/l

0.44

122

742

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

130

820

1.61

6.07

2.5

3.6

4.29

2.53

ratio

0.27

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

123

766

1.63

6.05

2.0

1.6

1.18

1.17

g/l

0.14

113

723

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

170

2.37

6.04

2.0

1.5

—

(40768443) Skin Pathology biopsy report

177

1201

1.50

5.97

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

130

824

1.60

5.95

1.9

2.2

38.60

37.94

g/l

0.59

110

709

(3014271) Vancomycin [Susceptibility]

147

2.46

5.93

3.8

2.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

115

709

1.64

5.89

2.0

2.3

0.00

g/l

-0.00

105

654

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

310

2333

1.36

5.87

3.5

2.5

66.62

67.45

ml/min/173m2

0.11

112

918

(3024891) Influenza virus A+B Ag [Presence] in Specimen

118

733

1.63

5.87

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.35

5.83

1.1

100.81

94.87

0.24

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

116

719

1.63

5.82

2.0

2.3

0.00

g/l

-0.00

105

655

(3019150) Specific gravity of Urine by Refractometry

732

6161

1.23

5.78

4.4

3.9

1.02

kg/l

0.53

141

914

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

187

1295

1.47

5.71

1.8

1.7

1.36

1.53

g/l

1.83

155

1089

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

117

732

1.62

5.67

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

125

796

1.59

5.63

1.5

1.4

219.56

281.34

ug/g

3.41

444

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

542

1.71

5.61

1.2

—

9.27

—

(3045414) Leukocytes [Presence] in Urine

181

1252

1.47

5.57

2.1

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

131

846

1.57

5.57

3.7

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1234

10958

1.18

5.48

4.4

3.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.96

5.40

2.0

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.96

5.40

2.0

2.2

—

(40761535) Cells panel - Urine sediment

306

2330

1.34

5.38

3.4

3.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

148

990

1.51

5.38

1.9

2.3

9.84

10.29

g/l

0.88

129

870

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

196

1387

1.43

5.36

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.73

5.36

1.5

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

396

1.81

5.25

1.7

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

593

1.65

5.18

9.5

5.5

586.44

1016.18

iu/ml

0.39

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

413

3299

1.28

5.13

3.1

2.8

6.29

8.67

umol/l

2.33

343

2873

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

177

2.22

5.12

2.5

2.9

36.20

40.27

0.67

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

459

1.74

5.10

1.2

1.3

72.55

35.35

u/l

0.65

395

(3027923) C peptide [Moles/volume] in Serum or Plasma

153

2.30

5.02

2.0

1.3

1.16

1.19

nmol/l

0.04

115

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

114

732

1.57

5.00

1.3

1.2

32.04

46.54

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.04

4.94

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3187

30688

1.21

4.89

22.9

15.1

139.52

139.66

mmol/l

2.33

3131

29854

(4146454) Self-monitoring of blood glucose

311

1.88

4.88

2.5

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

131

874

1.52

4.85

1.8

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

242

2.00

4.83

2.2

1.4

1.63

1.22

promille

0.83

182

(3004809) Band form neutrophils/100 leukocytes in Blood

444

1.73

4.83

4.7

3.8

1.20

1.47

0.42

393

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

107

685

1.58

4.77

1.3

1.2

13.59

6.81

u/ml

0.30

112

(3000060) B lymphocytes [#/volume] in Blood

2.89

4.75

1.4

2.0

142.50

171.54

e6/l

0.25

(3021788) Differential panel - Synovial fluid

485

1.68

4.72

1.5

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

608

5123

1.22

4.70

1.9

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1503

13687

1.16

4.69

3.1

2.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

103

657

1.58

4.67

5.4

3.2

25.06

27.00

mg/l

0.19

414

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.72

4.67

3.7

3.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

543

1.63

4.58

1.2

2.04

4.06

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

14.02

4.57

1.3

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

128

2.35

4.57

1.1

1.0

0.18

0.52

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

113

743

1.54

4.50

3.3

2.5

—

(44813793) Dust mix specific IgE antibody measurement

129

2.34

4.49

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

128

865

1.50

4.49

1.6

0.43

0.17

iu/ml

0.34

178

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

105

681

1.56

4.45

1.3

1.2

2.73

3.06

u/ml

—

(3037121) Protein [Mass/volume] in Urine

146

1015

1.46

4.45

3.5

3.1

0.35

0.37

g/l

0.08

425

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

487

1.66

4.40

1.1

4.79

1240.95

iu/ml

0.55

108

(3023103) Potassium [Moles/volume] in Serum or Plasma

3191

30802

1.19

4.40

23.0

15.3

3.98

mmol/l

0.22

3132

29913

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

815

1.50

4.33

1.9

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

197

1454

1.37

4.29

10.6

11.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

326

1.79

4.25

1.4

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

335

2673

1.28

4.22

2.4

2.2

0.21

g/l

0.14

319

2484

(40760888) Immunoglobulin light chains.free panel - Serum

636

1.55

4.17

2.6

3.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

140

983

1.44

4.08

1.2

0.18

0.74

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

287

1.82

4.06

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

129

2.26

4.05

1.8

2.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

266

1.85

4.03

1.5

1.3

145832.32

85243.38

e6/l

0.22

188

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

440

3643

1.23

4.03

8.1

6.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

123

2.29

4.03

1.3

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.94

4.00

1.0

1.1

10.51

14.69

u/ml

—

(21494814) CD8 cells/100 lymphocytes in Specimen

111

2.35

3.99

2.2

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.43

3.96

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

464

1.63

3.92

1.7

1.8

4.88

4.97

mmol/24h

0.10

408

(3010421) pH of Blood

107

720

1.50

3.88

3.0

3.4

7.41

7.42

0.25

642

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

246

1919

1.30

3.72

2.5

2.4

13.85

23.07

au/ml

—

170

(1761482) Bacteria [#/volume] in Urine by Culture

112

770

1.47

3.68

4.9

3.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

122

2.22

3.66

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

122

2.22

3.66

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2985

28774

1.16

3.66

5.0

4.3

6.07

5.95

mmol/l

3.87

2733

26236

(3016228) CD19 cells/100 cells in Blood

116

2.25

3.63

2.3

2.1

10.38

9.46

0.09

111

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

164

2.02

3.54

1.5

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

118

827

1.44

3.52

3.7

2.8

3.81

3.56

g/l

0.77

112

788

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

294

1.74

3.49

1.8

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

166

2.00

3.43

1.5

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.77

3.41

1.1

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

334

2735

1.24

3.41

2.7

2.4

31.75

56.29

u/l

0.80

287

2362

(3023183) Ammonium ion [Moles/volume] in Plasma

610

1.50

3.41

2.5

3.1

32.16

36.97

umol/l

1.15

552

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

174

1.96

3.38

1.5

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

222

1733

1.30

3.37

5.0

3.2

127.73

129.52

g/l

0.55

217

1692

(3027456) Digoxin [Moles/volume] in Serum or Plasma

547

1.53

3.37

3.3

3.0

0.85

0.79

nmol/l

0.26

411

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

213

1655

1.30

3.35

3.0

3.4

4.44

4.48

pmol/l

0.25

189

1457

(3020876) Protein [Mass/time] in 24 hour Urine

298

1.72

3.35

2.4

2.5

1.36

1.51

g/24h

0.16

142

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

352

2909

1.23

3.31

3.2

4.2

32.13

19.87

ug/l

0.22

295

2357

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.92

3.29

8.2

5.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

170

1.95

3.23

1.5

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

121

867

1.41

3.23

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

116

2.16

3.21

1.0

0.14

4.17

u/ml

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

371

1.63

3.20

2.7

2.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

660

1.47

3.20

1.9

1.5

—

(3012501) Base excess in Blood by calculation

611

1.48

3.19

3.1

3.6

2.54

2.45

mmol/l

0.10

383

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

591

1.48

3.09

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

462

1.55

3.08

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

209

1.83

3.08

1.6

1.5

85.11

82.99

umol/l

0.10

209

(3017446) Testosterone [Moles/volume] in Serum or Plasma

328

2715

1.23

3.05

2.4

2.2

12.90

13.28

nmol/l

0.42

298

2479

(3026389) Candida sp identified in Specimen by Organism specific culture

330

1.65

3.04

1.3

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.84

3.02

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

226

1796

1.27

3.02

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

270

1.71

3.00

3.1

2.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

147

1.98

2.99

1.3

—

218.00

—

(40757373) Influenza virus identified in Isolate

2.64

2.96

1.9

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

264

1.71

2.95

1.5

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

134

2.02

2.95

2.8

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

582

1.47

2.92

1.4

1.2

—

(3006270) Folate [Moles/volume] in Blood

250

1.73

2.91

1.2

390.19

359.31

nmol/l

0.38

219

(3052592) Norovirus Ag [Presence] in Stool

2.83

2.91

1.6

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

413

1.56

2.90

6.8

5.2

352.77

371.85

umol/l

0.53

355

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

374

1.59

2.88

1.4

1.3

0.61

0.60

nmol/l

0.04

362

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

692

1.43

2.87

2.1

146.63

93.40

ug/min

0.36

429

(3039000) Anion gap in Blood

595

1.46

2.81

6.2

7.4

11.48

11.41

mmol/l

0.06

532

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.23

2.79

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

596

1.45

2.79

6.2

7.4

104.59

105.41

mmol/l

0.82

533

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.92

2.77

1.0

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

101

723

1.41

2.76

1.2

1.3

453.35

516.47

mg/l

1.10

683

(3011985) Renin [Units/volume] in Plasma

355

1.59

2.75

1.4

89.45

51.76

mu/l

0.47

313

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

525

1.48

2.72

1.3

1.2

39.46

42.96

u/ml

0.07

(3000093) Morphology [Interpretation] in Blood Narrative

256

1.69

2.70

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

105

2.10

2.68

3.4

4.6

—

(3049717) Cytology report of Urine Cyto stain

143

1092

1.32

2.62

2.6

—

(3044941) Cell count panel - Synovial fluid

440

1.51

2.61

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

113

2.04

2.61

1.6

—

(36660697) Celiac disease serology panel - Serum

261

2149

1.23

2.59

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.67

2.59

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

135

1024

1.33

2.59

1.6

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

216

1743

1.25

2.58

10.0

9.5

1.50

1.31

1.62

216

1730

(3017569) Oxygen content in Arterial blood

107

2.06

2.56

1.9

2.1

—

(3021589) Normoblasts [#/volume] in Blood

1355

12624

1.11

2.56

11.6

9.2

0.00

e9/l

0.68

1131

10294

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

1.6

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

1.6

2.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

315

1.59

2.54

1.4

1.6

67.11

59.34

0.73

199

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

339

1.57

2.53

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.81

2.46

7.4

5.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

214

1736

1.25

2.45

10.2

9.7

0.69

0.68

0.12

214

1720

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

506

1.45

2.41

1.9

1.7

—

(3051651) Icteric interference index of Serum or Plasma

174

1.79

2.41

3.9

3.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

548

1.43

2.40

1.4

1.2

231.54

264.44

u/ml

0.55

352

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

2.01

2.40

2.4

2.1

139.53

173.71

umol/l

0.20

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

1.73

2.63

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

1.37

3.68

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

0.89

1.73

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.01

2.40

1.3

1.39

2.02

mg/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2930

28453

1.12

2.39

4.4

3.8

1.38

1.32

mmol/l

3.55

2687

26177

(3008037) Lactate [Moles/volume] in Venous blood

658

1.39

2.39

4.1

2.9

1.49

1.69

mmol/l

1.55

635

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

329

1.56

2.37

1.5

1.3

—

nmol/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.42

2.36

1.0

1.1

0.82

0.66

umol/24h

—

(3051611) Lipemic interference index of Serum or Plasma

290

1.59

2.36

3.5

3.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

275

1.61

2.34

1.6

2.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

109

816

1.35

2.32

1.8

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

339

1.54

2.32

1.3

1.4

272.31

281.13

pmol/l

0.09

292

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

536

1.43

2.31

3.0

3.7

60.63

57.08

1.75

536

(3045716) Anion gap in Serum or Plasma

119

1.94

2.30

2.0

2.6

9.26

10.39

mmol/l

0.42

114

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

598

1.40

2.25

3.4

1.9

0.95

0.83

nmol/l

0.63

505

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

142

1.84

2.22

1.7

1.8

2.60

2.34

u/field

0.07

101

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.05

2.21

5.6

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

108

815

1.33

2.20

1.2

1.3

178.13

213.66

miu/ml

0.58

350

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

730

1.35

2.17

1.1

7.90

5.75

u/ml

—

(3024263) Appearance of Synovial fluid

158

1.78

2.17

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

297

1.56

2.16

1.3

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

637

1.37

2.15

1.2

1.3

3.83

3.81

mmol/l

0.06

590

(3029937) Albumin [Presence] in Urine by Test strip

821

7506

1.12

2.15

4.4

3.9

0.00

estimate

0.06

260

2449

(3034274) Bile acid [Moles/volume] in Serum --fasting

282

1.57

2.13

1.8

2.1

5.07

9.21

umol/l

1.08

201

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

421

1.46

2.10

1.4

1.2

—

(3045142) Bone marrow Pathology biopsy report

324

1.52

2.08

1.2

1.4

—

(3002619) Bacteria identified in Specimen by Culture

2.56

2.07

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.00

2.07

2.2

2.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.91

2.07

1.2

1.3

—

581.16

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

191

1.68

2.06

1.1

1.0

664.43

725.93

ng/l

0.47

117

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.50

2.05

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.50

2.05

1.9

3.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

391

3417

1.16

2.05

1.9

1.6

—

(3011288) Drugs identified in Urine by Screen method

100

757

1.33

2.02

6.2

3.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

146

0.34

2.00

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

140

1.79

2.00

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

140

1.79

2.00

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

216

1.63

1.99

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

193

1.66

1.99

1.1

1.0

366.29

311.37

ng/l

0.30

123

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.28

1.97

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

622

1.36

1.97

4.3

2.9

7.04

7.70

mmol/l

1.80

604

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

194

1.65

1.96

1.1

1.0

55.33

42.77

ng/l

0.43

120

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

149

1.75

1.94

1.1

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

127

1.82

1.93

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.73

1.93

1.1

1.0

—

(3024471) HLA-A [Type]

106

1.89

1.90

1.1

1.0

—

(40761511) CBC panel - Blood by Automated count

3200

31345

1.11

1.87

18.5

12.3

—

(3006653) Thiamine [Moles/volume] in Blood

136

1.77

1.87

1.3

129.42

136.33

nmol/l

0.31

136

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

107

1.87

1.86

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

576

5205

1.12

1.85

2.9

3.1

2.45

mmol/l

0.38

500

4550

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

624

0.67

1.85

1.2

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

839

1.30

1.84

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

107

831

1.30

1.83

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.17

1.82

2.2

1.9

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.17

1.82

6.0

5.0

262.40

495.42

umol/l

—

(3044927) Protein electrophoresis panel - Urine

286

1.51

1.81

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

130

1.77

1.81

5.5

12.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

107

833

1.29

1.80

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.76

1.79

1.3

1.1

—

(21494755) Public health laboratory ask at order entry panel

280

3235

0.86

1.78

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.17

1.77

1.9

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3036

29683

1.10

1.76

4.8

4.2

4.58

4.65

mmol/l

3.10

2820

27640

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.03

1.74

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

170

1.65

1.73

1.4

23.25

18.96

u/ml

—

(3036489) Thrombin time

134

1080

1.25

1.72

2.6

2.3

22.22

21.23

0.45

119

950

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

135

1089

1.25

1.72

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

140

1.72

1.71

1.5

1.1

3.40

4.89

iu/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

474

1.38

1.71

1.2

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

638

1.32

1.70

1.3

1.5

511.75

831.61

e6/l

0.33

522

(3036782) Glucose [Moles/volume] in Pleural fluid

250

1.52

1.70

1.4

6.61

6.47

mmol/l

0.13

232

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3012

29456

1.10

1.69

4.8

4.2

1.38

1.42

mmol/l

6.75

2784

27286

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

156

1.67

1.68

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

587

0.68

1.68

1.2

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

553

1.34

1.68

2.6

2.2

16.02

16.47

0.54

253

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

151

1237

1.23

1.68

2.3

1.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

126

1.75

1.67

1.1

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

126

1.75

1.67

1.1

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

586

0.68

1.67

1.2

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

485

1.37

1.67

1.7

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.58

1.65

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.58

1.65

1.1

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.58

1.65

1.0

1.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

585

0.68

1.65

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

585

0.68

1.65

1.2

1.4

—

(3001729) Color of Synovial fluid

2.80

1.65

2.1

1.6

—

(3025130) Human papilloma virus identified in Specimen

293

1.47

1.64

1.8

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.03

1.64

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

335

1.44

1.63

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

511

0.66

1.62

1.3

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.38

1.61

1.8

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.87

1.60

2.5

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.00

1.59

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

638

1.31

1.57

1.2

1.4

6.19

24.30

e6/l

1.11

490

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.20

1.56

1.6

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.43

1.53

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.98

1.53

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

476

1.35

1.52

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.34

1.52

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

503

0.67

1.52

1.2

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

169

1.60

1.51

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.60

1.51

2.4

2.5

—

(3024928) Oxygen saturation in Venous blood

607

1.31

1.51

6.5

3.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

660

1.29

1.51

1.2

—

(40762814) Titanium [Mass/volume] in Blood

2.16

1.50

2.3

2.2

3.74

4.86

ug/l

—

(3005033) Fetal Nuchal fold Thickness US

501

0.68

1.49

1.2

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

104

831

1.26

1.48

5.8

4.1

3.92

3.91

mmol/l

0.12

104

822

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.44

1.47

1.9

1.5

88.78

135.11

ng/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

436

1.36

1.47

1.6

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.50

1.45

1.6

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.12

1.44

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

507

1.33

1.44

3.8

3.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

378

1.38

1.44

1.0

1.1

1.35

2.45

u/ml

2.26

186

(3005570) Glucose [Moles/volume] in Urine

294

1.43

1.7

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

156

1.61

1.43

1.0

—

(3037756) Immunofixation for Serum or Plasma

560

1.31

1.43

1.9

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

543

1.31

1.42

1.7

1.4

110.18

121.01

u/ml

0.42

103

(3010375) cycloSPORINE [Mass/volume] in Blood

141

1.63

1.41

28.0

22.8

95.61

112.05

ug/l

0.60

115

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

100

802

1.25

1.39

3.7

3.3

1.59

1.51

mg/l

0.36

738

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.42

1.39

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.89

1.38

1.3

1.2

35.62

38.71

g/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

111

1.71

1.38

1.2

—

(3003181) Sodium [Moles/volume] in Urine

467

1.33

1.38

1.5

1.3

60.31

63.83

mmol/l

0.32

374

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

364

1.38

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.00

1.38

1.0

—

(3024932) HLA-DR beta [Type]

104

1.73

1.36

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3265

32134

1.10

1.36

12.6

9.7

27.72

27.59

u/l

0.14

3175

30951

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.94

1.36

1.0

1.1

—

9.14

iu/ml

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.83

1.35

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

258

2265

1.15

1.35

1.5

—

(3035880) pH of Pleural fluid

143

1.61

1.35

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

461

1.33

1.34

1.4

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

700

6506

1.09

1.33

3.8

3.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1166

11070

1.08

1.31

4.4

4.5

3.16

3.27

ug/l

0.05

1058

10001

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.74

1.30

3.0

2.8

24.45

28.91

umol/l

0.75

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

242

1.45

1.29

1.1

287.86

284.38

mg/l

0.13

221

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

310

2766

1.13

1.28

2.1

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.89

1.28

1.6

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

251

1.44

1.28

2.3

2.2

1.00

2.17

u/field

1.39

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.72

1.27

1.6

2.0

9.69

9.58

mg/l

0.02

(1001926) Buprenorphine [Presence] in Urine by Screen method

110

903

1.22

1.26

3.0

2.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

334

2997

1.12

1.26

3.6

3.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

328

1.38

1.26

1.0

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.40

1.24

1.2

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

109

897

1.22

1.23

3.2

2.3

687.75

5186.79

u/l

4.73

355

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

1.57

1.22

1.5

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

296

1.39

1.22

1.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3075

30226

1.08

1.22

5.1

4.6

2.73

2.77

mmol/l

1.85

2845

27966

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

116

1.64

1.21

3.5

3.0

—

(3002256) Pathology report gross observation

405

3687

1.11

1.20

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.83

1.19

1.9

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

141

1.56

1.17

2.1

3.5

—

(3025577) Chromium [Mass/volume] in Blood

174

1.50

1.15

2.3

2.0

2.75

1.94

ug/l

0.56

147

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

275

1.39

1.13

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1030

0.81

1.12

1.4

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

143

1.54

1.11

1.2

1.1

—

10.42

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.96

1.11

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

495

1.28

1.09

3.6

3.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.95

1.08

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

1.52

1.08

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

1.53

1.08

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

160

1384

1.16

1.07

1.3

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.93

1.06

2.2

2.0

15.72

16.30

umol/l

—

(3028300) Cannabinoids [Presence] in Urine

137

1173

1.17

1.05

2.8

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

331

1.33

1.05

1.5

1945.40

1612.60

e6/l

0.29

241

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.27

1.03

4.6

4.8

1.44

1.06

mg/l

—

(3024869) Neuronal Ab [Presence] in Serum

1.96

1.03

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

263

1.37

1.03

1.1

1.0

—

(3033658) Prothrombin time (PT) actual/Normal

791

7471

1.07

1.03

5.0

3.9

89.73

89.01

0.32

766

7295

(3000034) Microalbumin [Mass/volume] in Urine

247

1.38

1.01

3.2

3.3

155.97

37.21

mg/l

0.79

190

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

351

1.31

1.00

1.2

1.3

16.27

24.03

u/l

1.37

291

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.88

1.00

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

1.00

1.1

—

(3012441) Differential panel - Pleural fluid

282

1.35

1.00

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

343

1.32

0.99

2.2

2.1

21.88

23.82

mg/l

0.13

(3027008) Opiates [Presence] in Urine

136

1171

1.17

0.99

2.7

2.2

—

(3048879) Bone marrow aspiration report

1.71

0.98

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.81

0.98

2.5

1.2

18.63

16.40

umol/l

0.58

(3050794) Legionella sp Ab [Presence] in Serum

2.18

0.98

1.2

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.63

0.97

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.85

0.96

2.8

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

595

1.23

0.96

1.8

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

157

1.47

0.95

1.0

1.1

0.99

1.13

u/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.95

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

174

1.44

0.95

1.4

1.6

6.05

6.92

u/l

0.16

143

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

596

1.23

0.94

3.4

3.7

276.58

924.56

u/ml

0.66

553

(3016879) Cocaine [Presence] in Urine

126

1083

1.17

0.94

2.8

2.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.22

0.93

2.5

1.4

—

(40768806) Pleura Pathology biopsy report

286

1.33

0.93

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.72

0.92

1.3

348.13

554.39

ug/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.73

0.92

2.0

3.2

—

(3008898) HLA-B27 [Presence]

107

910

1.18

0.92

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.14

0.91

1.8

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

261

1.34

0.91

1.6

1.5

26.83

29.08

0.15

165

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

253

1.35

0.90

1.2

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.07

0.89

1.2

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.79

0.87

3.8

6.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.79

0.87

1.3

1.2

31.32

77.32

ng/l

—

(1002224) Polysomnography panel

145

1269

1.15

0.87

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

134

1166

1.15

0.87

2.8

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.86

0.87

11.0

13.6

5.64

5.75

mmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

476

1.24

0.87

1.2

—

(4212803) Bone marrow aspirate examination

2.00

0.87

1.2

1.0

—

(3036180) Methadone [Presence] in Urine

153

1.44

0.85

1.8

3.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

586

1.22

0.85

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

187

1.39

0.85

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

187

1.39

0.85

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

187

1.39

0.85

1.3

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

114

0.53

0.82

3.0

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

114

0.53

0.82

6.0

6.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

800

1.18

0.82

1.2

111.25

102.95

titre

—

(3004451) EKG impression Narrative

138

1.45

0.81

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.61

0.81

1.2

1.5

66.77

112.31

nmol/24h

1.94

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.57

0.81

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1.38

0.80

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1.38

0.80

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

189

1.38

0.80

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

582

1.21

0.79

1.1

1.4

—

(3020491) Glucose [Moles/volume] in Blood

224

1.34

0.79

1.3

2.1

8.00

6.72

mmol/l

0.77

148

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

207

1.36

0.79

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

250

2280

1.10

0.78

3.2

3.8

1.22

1.23

mmol/l

0.98

220

1981

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

366

1.26

0.78

1.3

7.09

7.18

mmol/l

0.08

319

(3003694) ABO and Rh group [Type] in Blood

795

8325

0.94

0.78

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

334

3091

1.09

0.77

2.3

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

834

0.84

0.77

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.76

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

130

1145

1.14

0.75

1.9

2.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.08

0.74

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

689

1.18

0.73

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

184

1.36

0.73

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.80

0.72

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

202

1.34

0.72

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.52

0.72

1.1

—

(3047189) Immunofixation for 24 hour Urine

134

1.42

0.71

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.58

0.71

1.1

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.92

0.70

2.0

2.4

0.60

0.73

u/field

—

(3001556) Androgen free Index in Serum or Plasma

1.85

0.68

1.0

1.3

—

(3008607) Semen analysis panel

1.85

0.68

1.0

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.56

0.68

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.53

0.68

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.53

0.68

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.53

0.68

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.53

0.68

1.2

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.60

0.68

7.3

5.6

67.83

70.74

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

144

1.39

0.67

1.1

1.2

—

68.28

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

274

2957

0.92

0.66

1.8

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

642

1.17

0.65

1.5

1.9

912.90

4.75

iu/l

0.48

225

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

112

1.43

0.63

1.1

1275.60

292.89

ng/l

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

104

1.44

0.62

1.2

1.1

—

(3020891) Body temperature

122

1088

1.13

0.61

5.7

4.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

113

1.42

0.61

1.1

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

298

1.24

0.60

1.5

1.4

49019.46

79164.98

e6/l

0.35

182

(3003338) MCHC [Mass/volume]

2567

26029

0.96

0.60

25.1

16.7

332.38

333.14

g/l

3.84

2550

25779

(3039443) Prostate specific Ag panel - Serum or Plasma

816

1.14

0.60

1.4

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

835

1.14

0.60

1.5

1.4

7.96

8.75

u/l

0.29

685

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

317

1.23

0.59

2.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

693

0.85

0.59

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

254

1.26

0.59

1.3

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.59

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

299

1.24

0.59

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

117

1044

1.12

0.59

2.1

3.3

2195.17

4350.75

u/ml

0.29

900

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

783

7532

1.05

0.58

1.6

1.47

1.40

mmol/l

1.26

662

6359

(3002079) Sodium [Moles/time] in 24 hour Urine

114

1.40

0.58

1.4

1.2

145.94

181.26

mmol/24h

1.11

114

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

171

1560

1.10

0.58

2.4

1.9

—

(3034770) Mitochondria Ab [Titer] in Serum

791

1.14

0.58

1.2

—

1313.04

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

173

0.69

0.57

5.7

7.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

202

1.29

0.57

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.51

0.56

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

191

1757

1.09

0.55

1.2

126.89

148.86

iu/ml

0.35

634

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

133

1.35

0.55

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

168

1.31

0.54

9.6

6.8

43.50

14885.46

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.58

0.54

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

186

1.29

0.54

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

186

1.29

0.54

1.2

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

180

1954

0.92

0.53

1.5

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.45

0.53

1.4

3.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

286

1.23

0.52

1.2

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

196

1.28

0.52

1.4

2.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

143

1.33

0.52

1.4

1.3

5.70

5.93

mmol/l

0.45

137

(3019897) Erythrocyte distribution width [Ratio] by Automated count

391

0.82

0.51

3.6

2.3

13.25

13.14

0.29

386

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.49

0.49

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

418

1.17

0.48

1.1

113.74

113.81

0.00

383

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

140

1281

1.10

0.48

3.0

3.3

75.87

66.83

u/ml

0.11

130

1241

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

452

4316

1.05

0.47

1.7

1.6

—

(40768800) Prostate Pathology biopsy report

613

0.86

0.47

1.2

—

(3045788) Cell count panel - Pleural fluid

254

1.22

0.46

1.5

—

(40758292) HTLV I+II Ab panel - Serum

1.46

0.46

1.4

1.5

—

(40768793) Breast Pathology biopsy report

580

0.86

0.46

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

270

2541

1.07

0.46

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

199

0.75

0.46

1.8

1.5

—

(3044889) 12 lead EKG panel

2097

20653

1.03

0.46

4.1

3.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

200

1.25

0.46

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

200

1.25

0.46

1.1

—

(3015183) Erythrocyte sedimentation rate

153

0.72

0.45

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

231

0.78

0.44

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.40

0.44

1.2

1.1

87.92

100.97

0.46

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.37

0.44

1.7

3.1

82.30

108.05

ng/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

3391

33702

1.05

0.42

29.1

19.4

40.31

40.65

0.78

3216

31585

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

222

1.22

0.41

2.3

2.0

637.00

608.54

0.16

146

(3006922) Hepatitis E virus Ab [Presence] in Serum

213

1.22

0.40

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.39

0.40

1.1

—

(3007461) Platelets [#/volume] in Blood

3393

33728

1.04

0.40

29.0

19.2

253.96

246.58

e9/l

8.53

3336

32815

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.47

0.40

2.8

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

249

0.80

0.40

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

103

0.68

0.39

1.3

1.2

—

0.26

g/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.43

0.39

10.0

5.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.43

0.39

1.0

1.1

—

(3000012) Reticulocyte production index

389

0.85

0.39

1.5

2.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.39

0.38

1.2

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.39

0.38

1.0

2.5

—

(4034850) Laboratory test

936

0.91

0.38

14.9

9.8

—

(21494434) Karyotype in Bone marrow

252

1.19

0.37

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.37

1.0

1.1

1.66

1.70

umol/24h

—

(3035941) MCH [Entitic mass]

3394

33752

1.04

0.37

28.9

19.1

30.26

30.36

2.41

3362

33215

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

1.29

0.37

1.1

—

(3024731) MCV [Entitic volume]

3394

33754

1.04

0.36

28.9

19.2

90.93

90.94

0.02

3362

33217

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.62

0.35

1.6

1.3

8.80

9.08

ug/l

—

(3026361) Erythrocytes [#/volume] in Blood

3394

33759

1.04

0.35

29.0

19.2

4.52

4.53

e12/l

0.31

3330

32752

(3022493) Free Hemoglobin [Mass/volume] in Plasma

126

1.27

0.35

1.8

7.1

62.56

69.47

mg/l

—

(1761868) Lipid panel - Serum or Plasma

1080

11026

0.97

0.34

3.0

2.7

—

(3002385) Erythrocyte distribution width [Ratio]

2592

25677

1.03

0.34

22.9

15.7

15.44

14.97

1.45

2560

25144

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

518

1.12

0.34

1.1

—

(3017704) Immunofixation for Urine

156

0.77

0.34

2.8

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

136

1.25

0.33

1.1

—

(3006462) Nitrate [Presence] in Urine

127

1.26

0.33

6.8

3.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

127

1.26

0.33

1.1

1.0

87.55

95.34

0.65

(3010813) Leukocytes [#/volume] in Blood

3394

33767

1.04

0.33

29.1

19.2

7.15

6.66

e9/l

24.98

3327

32753

(3011648) Oxygen content in Venous blood

247

1.18

0.32

2.3

2.6

11.29

11.53

0.12

247

(3000963) Hemoglobin [Mass/volume] in Blood

3394

33769

1.04

0.32

29.2

19.3

135.94

136.67

g/l

1.94

3361

33235

(4094501) Cardiovascular stress test using bicycle ergometer

812

0.91

0.32

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

187

0.80

0.32

1.6

1.7

—

(3011436) Histone Ab [Units/volume] in Serum

1.35

0.31

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.35

0.31

1.3

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

106

984

1.08

0.31

1.8

1.6

261.81

293.81

mu/l

0.91

900

(3033799) Differential panel - Peritoneal fluid

100

0.70

0.30

2.7

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

431

0.88

0.30

2.1

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

111

0.72

0.28

1.3

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

440

1.11

0.28

1.1

1.2

2.06

2.96

u/ml

0.54

146

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

317

1.14

0.28

1.2

1.1

92.17

96.04

0.31

303

(4035726) Immunohistochemistry procedure

261

2505

1.04

0.27

1.5

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

1.24

0.24

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

208

1.15

0.24

2.0

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

437

1.10

0.23

1.1

1.2

4.50

3.97

u/ml

0.17

204

(3014891) Appearance of Pleural fluid

1.25

0.22

2.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.75

0.22

1.1

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

900

8850

1.02

0.22

3.7

3.9

22.68

21.84

0.83

390

3970

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.19

0.21

1.0

1.8

0.92

1.46

mg/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

369

3792

0.97

0.21

1.5

1.4

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

7.91

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

36.98

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

21.00

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

102

0.78

0.21

1.1

1.5

14.72

14.78

pmol/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

102

0.78

0.21

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

354

1.10

0.20

1.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

295

2861

1.03

0.20

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

441

1.09

0.20

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

203

1.13

0.19

1.3

1.54

1.53

g/l

0.02

203

(3023383) Lactate [Moles/volume] in Pleural fluid

1.24

0.18

1.5

1.4

3.21

3.30

mmol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.21

0.17

2.2

1.8

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

299

0.90

0.17

2.2

2.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

107

1120

0.95

0.17

2.0

1.7

5.35

3.73

mg/l

0.65

801

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.16

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.13

0.16

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

149

1.14

0.15

1.7

2.1

—

(3008295) Osmolality of Serum or Plasma

293

1.09

0.15

1.5

1.4

279.00

280.36

mosm/kgh2o

0.14

222

(3035933) Granulocytes/100 leukocytes in Blood

1.08

0.14

1.7

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

307

3138

0.98

0.14

1.7

—

(40765096) Chromosome analysis panel by Banding

0.82

0.13

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

286

1.08

0.13

1.3

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

111

1151

0.96

0.13

1.5

1.3

22.26

25.72

iu/l

0.59

987

(3016650) Hepatitis A virus Ab [Presence] in Serum

499

0.94

0.13

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

952

1.04

0.13

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

142

1.13

0.12

9.1

3.7

—

(4281824) Cell count and differential, peritoneal fluid

288

1.08

0.11

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

153

1.11

0.11

1.2

1.4

—

(3034426) Prothrombin time (PT)

105

1.14

0.11

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

270

1.07

0.10

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

152

1482

1.03

0.10

1.5

1.6

—

(40768441) Liver Pathology biopsy report

218

0.92

0.10

1.4

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

135

0.89

0.09

1.3

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.11

0.09

1.2

1.1

—

3.72

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

114

0.88

0.09

1.1

1736.20

1588.51

miu/ml

—

114

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

155

1.10

0.09

2.6

2.1

1399.20

160.91

ug/min

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

321

1.06

0.09

2.1

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.09

0.08

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.03

0.08

1.7

2.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.78

0.08

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.03

0.07

1.7

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.84

0.07

1.5

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.07

0.07

7.5

7.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

316

0.95

0.07

1.4

147.47

200.78

pmol/l

0.95

316

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.11

0.06

1.0

2.2

1.35

1.09

ug/l

0.14

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

168

1.07

0.06

1.3

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

296

1.05

0.05

1.1

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

641

6445

0.99

0.05

2.7

2.8

0.76

ug/l

0.00

383

4020

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

493

0.97

0.04

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

241

2391

1.01

0.03

4.3

3.9

—

(3009871) Measles virus Ab [Titer] in Serum

1.09

0.03

1.7

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

263

1.03

0.01

3.4

5.3

28.53

74.70

u/ml

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

577

0.99

0.01

1.6

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

204

1.03

0.00

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

161

0.99

0.00

1.3

1.4

5.44

7.60

u/l

—

137

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

2761.10

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.95

-0.00

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

0.89

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.32

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.0

—

4.34

—

(3022689) Creatine [Moles/volume] in Urine

0.96

-0.00

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.89

-0.00

1.0

1.2

—

118.60

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.91

-0.00

8.4

7.1

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

2.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.43

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.01

-0.00

1.3

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.96

-0.00

1.7

2.0

264.67

177.06

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.00

-0.00

8.0

7.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_BRONCH and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_BRONCH	1.698 [1.51, 1.91]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.384

During the follow-up period (1.1.1998 — 31.12.2019), 1909 out of 5827 females with J10_BRONCH died.

Males

Parameter	HR [95% CI]	p-value
J10_BRONCH	2.105 [1.81, 2.44]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 1998 out of 5250 males with J10_BRONCH died.

Mortality risk

Mortality risk for people of age

years, who have J10_BRONCH.

N-year risk	Females	Males
1	0.114%	0.399%
5	1.039%	2.452%
10	2.624%	6.119%
15	5.02%	11.305%
20	8.786%	18.783%

Relationships between endpoints

↥

Index endpoint: J10_BRONCH – Bronchitis, not specified as acute or chronic

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bronchitis, not specified as acute or chronic

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints